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 I Introduction 
1. Regulation of blood flow in the vascular system 
The human vascular system represents a distinct organ that by containing blood and 
regulating its flow serves a wide range of functions: transport of blood gases and nutrients, 
elimination of metabolic products, pH regulation and immune function are just some 
examples [1]. In humans it functions as a closed system. Although the basic anatomy of this 
system has already been known in ancient Egypt and India [2], only in the 16
th
 and 17
th
 
century some of the underlying mechanisms were uncovered [3]. 
To fulfill its multiple roles every single part is optimized for its specific function: While 
arteries serve as high pressure conductors away from the heart, veins conduct blood back to 
the heart [4]. Arteries, depending on their size, function as a conduit or resistance vessel, the 
latter regulating vascular diameter and therefore blood flow according to current metabolic 
needs (Figure I-1) [5]. Capillaries have very thin walls consisting of only a single layer of 
endothelial cells adapted specifically to facilitate free diffusion of oxygen and other 
metabolites [4]. 
 
Figure I-1: Vessel wall of a small, muscular artery: The arterial wall in principle consists of three 
distinct layers with distinct predominating cells types. The Tunica intima is formed by a single layer of 
endothelial cells that function as an adaptive barrier between the blood stream and the underlying 
tissue. The composition of the subjacent Tunica media depends on the size of the artery. While larger 
vessel walls comprise a higher content of elastic fibers, smaller arteries and arterioles such as the one 
depicted contain mainly smooth muscle cells by which they are able regulate vascular tone by 
contraction or relaxation. The third layer, called Tunica adventitia is made mainly of connective tissue 
that supports the vessel in the surrounding tissue. (image redrawn and modified based on 1) 
Fundamentally three distinct types of cells are responsible to ensure proper micro-vascular 
function: endothelial cells as the contact layer to the blood compartment, smooth muscle cells 
                                                 
1
 http://upload.wikimedia.org/wikipedia/commons/0/05/Anatomy_artery.png; Original image from Stijn A.I. 
Ghesquiere (www.applesnail.net) under license CC BY-NC-SA, retrieved on 10.08.2010 
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as regulators of vascular tone and pericytes serving as multipurpose cells coordinating and 
save-guarding vascular function [1]. 
 Smooth muscle cells regulate vascular diameter 1.1.
Smooth muscle cells in the wall of small arteries and in particular, arterioles represent the 
effector cells regulating local and, as a whole, global blood flow in every organ. Their main 
task is to assure an adequate distribution of nutrients and oxygen adapted to the current 
metabolic need of the individual tissue [6, 7] while maintaining an adequate arterial blood 
pressure. 
Three major regulatory mechanisms exist that are differentially active in different regions of 
resistance arteries. Metabolic regulation adapts the tissue blood supply to the current 
metabolic needs by vasodilation of the supporting small arteries if products related to tissue 
activity accumulate [8]. Autoregulation on the other hand aims at keeping blood flow and 
capillary pressure stable under varying blood pressures [9, 10]. The underlying Bayliss effect 
has been shown among others to be mediated by diacylglycerol-sensitive canonical transient 
receptor potential (TRPC) subunits that lead to a depolarization of the cellular membrane 
upon increases of blood pressure and vice versa [11-14]. Finally, the endothelium exerts vital 
effects on vascular smooth muscle cells. It regulates vascular tone via the release of signaling 
molecules such as NO, prostacyclin and endothelin, but also by direct signal exchange via 
myo-endothelial junctions [15-17]. Under disease conditions some of these mechanisms 
become also activated by immune cells which may then lead to a stronger perfusion of the 
inflamed tissue [4, 18]. 
 Endothelium is involved in blood flow regulation 1.2.
The endothelium forms a thin layer lining the interior of blood vessels in the entire circulatory 
system. It has a pivotal function in vascular signaling: on the one hand it acts as a sensor. E.g. 
it is responsive to shear stress or vasoactive blood constituents such as histamine which bind 
to endothelial receptors. In either case endothelial mediators are released and diffuse to the 
underlying smooth muscle cells [15, 17].  
Among these vaso-active endothelial mediators are nitric oxide (NO), lipid mediators such as 
prostaglandins and the endothelium derived hyperpolarizing factor (EDHF). These substances 
regulate vascular tone and therefore blood flow to the affected organ [15-17]. Especially by 
EDHF signaling, it serves a very important function in the coordination of blood flow 
regulation in microvascular networks [19-21]. 
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2. Gap junctional coupling in coordinating vascular 
responses 
 Connexins connect the cytoplasm of two adjacent cells 2.1.
Connexins comprise a family of transmembrane proteins in vertebrates. They are able to form 
so called gap junction channels connecting the cytoplasm of two adjacent cells. For this 
purpose six connexin proteins in a circular arrangement are necessary to form a single 
connexon and in turn two connexons (hemi-channels) form a functional gap junction pore as 
depicted in Figure I-2 [22-24]. 
 
Figure I-2: Schematic representation of a section through gap junction channels in the membranes of 
two adjacent cells. Individual connexons in the membrane bilayer are composed of six connexin 
proteins each. Always two channels in adjacent cells form one functional gap junction channel (image 
redrawn based on a part of 2) 
Cellular coupling represents a well-controlled process. Depending on their connexin 
expression pattern neighboring cells that both express connexins can be coupled but this is not 
imperative. The type of connexin expressed also has great influence on the permeability and 
selectivity of the gap junction channel. In humans, 21 different connexins have been 
discovered. Connexin proteins are commonly named by the letters “Cx” followed by their 
respective molecular mass in kilo-Dalton (kDa) [25]. They differ in their characteristics 
determining channel permeability, but also in the length and amino acid sequence of their 
carboxyl tail whereas the channel building N-terminal part has highly conserved regions. The 
C-terminal tail has many sites for posttranslational modifications and binding sites for protein 
interaction partners and is therefore also involved in channel independent intracellular 
signaling, most likely functioning as an adapter protein [26-28]. 
Connexins are essential in a wide spectrum of physiological processes in cardiovascular 
physiology. In the heart, electrical coupling of cardiomyocytes via gap junction channels 
formed mainly by connexin 43 (Cx43) ensures propagation of action potentials [29]. In the 
vascular system, the expression of connexins Cx37, Cx40, Cx43 and Cx45 has been reported 
[30, 31]. Interestingly, the expression of these four gap junction proteins is non-redundant, 
                                                 
2
 http://upload.wikimedia.org/wikipedia/commons/c/c6/Connexon_and_connexin_structure.svg; Original image 
is in the public domain, retrieved on 13.05.2009 
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meaning one connexin cannot completely take over the function of another connexin. While 
the expression of Cx45 seems to be restricted to smooth muscle cells [32, 33], Cx37 and Cx40 
are expressed primarily in endothelial cells [34, 35]. Cx43 as one of the most abundantly 
expressed connexins in humans can be found in both cells types [34, 36, 37]. Depending on 
the connexin proteins forming the pore, gap junctions allow not only the flow of ions as an 
electrical current but also the exchange of small signaling molecules such as IP3 [38-40] up to 
a molecular weight of around 1 kDa [41-44]. Recently also the passage of the significantly 
larger molecule Calmodulin with 17 kDa has been reported [45]. 
 The vessel wall forms a functional syncytium 2.2.
2.2.1. Coordinated regulation of blood flow 
Blood flow to organs and tissues in the human body is not steady but constantly adapting to 
changing metabolic and functional demands. Therefore, in a wide network of resistance 
arteries and capillaries all vascular cells have to act together in a coordinated manner to allow 
proper vascular function. Local changes in vessel diameter are only of limited effect since 
upstream segments contribute significantly to the total flow resistance in a given section of 
the vascular system. To this end vascular cells, especially endothelial cells, are coupled to 
neighboring cells, forming a functional syncytium with the aim of concerted vascular activity 
first described by Duling [46] in 1970. It has been found to be related to membrane potential 
[47, 48] and even acts over distances of more than 2mm [19]. Potentially on such a long 
journey the signal is even regenerated [49, 50]. 
Experimentally a local application of noradrenalin near capillaries induces a bidirectional 
conduction of vasoconstriction to the adjacent arterioles and venules [51]. In the same way 
local stimulation with endothelium derived hyperpolarizing factor (EDHF) stimulating agents 
such as acetylcholine induces a local endothelial hyperpolarization that is conducted further 
along the vessel wall [52]. The primary means of conduction is gap junctional coupling 
between endothelial cells. This mechanism leads in the case of EDHF to a simultaneous 
dilation of upstream arterioles [48]. Interestingly, dilations propagate over longer distances 
than constrictions. In the end this process leads to an “integrated response” of large feeder 
arteries and their distal daughter vessels [19, 53, 54], in which the overall conductivity of the 
vascular bed has been shown to play a vital role [54, 55]. 
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Figure I-3: Principle of conducted dilation. Local stimulation of an arteriole by application of the EDHF 
stimulator acetylcholine (ACh) induces a vasodilation in the vessel (left). This signal is relayed and in 
turn leads to a remote vasodilation in the supplying vessels (right). In contrast the local dilation by 
SNP which does not induce hyperpolarization is not transduced upstream. Inserted data images 
taken from: [20] 
2.2.2. Regulation of vessel development 
Proper coupling of cells in the vascular wall could be shown to be essential for proper 
formation and maintenance of blood vessels. In this respect, mice deficient for connexin 45 
exhibited severe defects in the maturation of their vascular system [56]. Although in these 
animals vasculogenesis seemed to be normal, they showed an impairment of transformation 
into mature vessels. In coronary arteries deficiency in connexin 43 leads to malformations, 
while loss of connexins 37 and 40 induced cavernous hemangioma formation [57]. 
Functionally endothelial cells in the vessel wall signals seem to require gap junctional 
communication for the activation of TGF-β and terminal cell differentiation of pericytes as 
well as endothelial cells [58]. 
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3. Pericytes serve as multi-purpose cells in the vessel wall 
Pericytes represent a cell population in the wall of small blood vessels that is difficult to 
characterize. Since their initial description in 1873 by Rouget [59] only limited progress has 
been made for pericytes. They were further characterized by Zimmermann in 1923 [60] and 
subsequently referred to as “Zimmermann’s cells”. After the first electron microscopy studies 
had been published in 1956 [61] Kuwabara independently re-discovered pericytes as so called 
“intramural cells” in 1961. Finally in 1966 Ashton and Olivera proposed that these two 
entities might essentially be the same cells [62]. 
Although some amount of data has been collected on pericytes since their first discovery, only 
very little is known on skeletal muscle pericytes. One reason is the fact that pericytes are a 
heterogeneous group of cells that exhibit major differences depending on the tissue they have 
been isolated from [63, 64]. This is even complicated more by the fact that apparently 
terminal pericyte differentiation can encompass a whole spectrum of endothelial cell, SMC 
and fibroblast markers and characteristics that make the status of these cells rather points on a 
continuum than a clearly distinguishable cell population [65-67]. Therefore phenotype, 
expression of surface markers and respective function remain a subject of lively debate in the 
literature. 
The great variability of pericyte phenotypes has been summarized by Shepro already in 1993 
as follows: They “regulate endothelial proliferation and differentiation; contract in manners 
that either exacerbate or stem endothelial cell junctional inflammatory leakage; function as a 
progenitor cell; synthesize and secrete a wide variety of vaso-active, autoregulating agonists; 
synthesize and release structural constituents of the basement membrane and extracellular 
matrix. Pericytes are also involved in specific microvascular diseases.” [68] 
 Morphology and localization 3.1.
Pericytes are perivascular cells that can be found close to capillaries, pre-capillary arterioles, 
post-capillary venules and collecting venules [69]. They possess a cell body with a prominent 
nucleus and extend long cytoplasmic processes that encircle the vessel wall.[70] A single 
pericyte covers a large vascular area comprising multiple endothelial cells. Interestingly, 
pericyte numbers vary greatly depending on the tissue. Relatively low numbers of pericytes 
are found in skeletal muscle with one pericyte per every 100 endothelial cells compared to for 
example the retina with a one on one ratio [68, 69]. 
Pericytes are equally heterogeneous in their protein expression pattern as they are in their 
phenotypes [63-67]. Smooth muscle actin (αSMA), desmin, the proteoglycan NG2, platelet-
derived growth factor receptor β (PDGFR-β) and pAPN/CD13 (aminopeptidase N) have been 
used and validated in previous studies as pericyte markers [63, 66, 69, 71-75]. Unfortunately, 
none of those molecules is expressed exclusively in pericytes and could therefore serve as an 
exclusive marker for the detection of pericytes in tissue sections or flow-cytometry. One of 
the reasons for this heterogeneity lies in the ability of pericytes to transdifferentiate into other 
cell types such as smooth muscle cells and fibroblasts [71]. Pericytes at any given tissue and 
vascular bed might therefore just represent a specific point in a continuum of pericytic 
phenotypes. Another factor in pericyte heterogeneity is the formation of mature pericytes and 
perivascular macrophages through cell fusion of bone marrow-derived cells (BMDCs) with 
yet unknown partner cells leading to multiple slightly different phenotypes [76]. 
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Figure I-4: Schematic representation of the localization of pericytes in the vascular system. In situ 
pericytes are large, flat cells with far reaching protrusions. They mainly reside around small vessels in 
the microcirculation, where they may provide mechanical stabilization for the vessel. Image modified 
after: [77] 
 Physiological functions 3.2.
Pericytes reside at the interface between the endothelium and the underlying smooth muscle 
cells and connective tissue. They therefore are at the crossroads to actively regulate and 
coordinate processes such as angiogenesis and vascular tone [78, 79]. Their functions seem to 
be tissue specific; therefore not every item on the following listing of functions might be 
applicable to every pericyte in every location. 
3.2.1. Mechanical stabilization and interaction with microvessels 
Pericytes are producers as well as resorbers of the extracellular matrix and through this 
actively contribute to the connective tissue matrix surrounding blood vessels [70]. 
Morphologically they share a close homology to vascular smooth muscle cells and as 
mentioned above might even have the potential to differentiate into them. They also express 
some classical SMC marker proteins such as αSMA and vimentin. This function has been 
studied extensively in CNS capillary pericytes. Since they are essentially contractile cells, 
they are considered to have the ability to contribute to the regulation of blood flow and 
regulation of vascular permeability at the capillary level [80, 81]. This has been shown under 
certain experimental conditions also in the retina [81]. To fulfill their constrictive function in 
capillaries (the physiologic meaning of which is absolutely unclear) pericytes express the 
contractile proteins actin and myosin. There are however prominent differences in the 
expression pattern of those markers in pericyte populations originating from different tissues 
and vascular beds [66, 82, 83]. 
3.2.2. Sensing and integrating mechanical and chemical stimuli 
In the control of vascular integrity and function pericytes have the ability to sense a variety of 
metabolic stimuli, integrate these signals and react either by sending signals to neighboring 
cells or by contracting or relaxing themselves, thereby directly influencing vascular tone [84-
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87]. In this respect in vitro studies suggest a role for pericytes in oxygen and carbon dioxide 
sensing and thereby an involvement in the regulation of adequate tissue perfusion [88-91]. 
Metabolic activity also leads to characteristic physiological changes that can be sensed by 
pericytes. In this respect an acidic extracellular pH [92] as well as increasing levels of the 
ATP breakdown product adenosine induced pericyte relaxations in vitro [93]. Reports on a 
concentration dependent effect did not specifically indicate pericyte involvement although 
this has been speculated in kidney vessels [94, 95]. Adenosine signaling via A1 and A2A 
receptors also could be shown to lead to the upregulation of KATP channel activity [96]. These 
KATP channels are inherently metabolically regulated with an increase in activity when the 
intracellular ATP level decreases leading to a hyperpolarization of the cell and therefore 
favoring dilation [96, 97]. 
The endothelial relaxation signal NO also leads to a relaxation in vascular pericytes [98]. 
Interestingly the metabolite lactate has a constricting effect when the supply of oxygen is high 
but can also lead to a relaxation under hypoxic conditions [87]. This constriction is also 
speculated to involve communication with endothelial cells, while hypoxia closes gap 
junctions between pericytes and endothelial cells [87]. Furthermore a wide range of 
vasoactive molecules have been described to be sensed by pericytes and induce a reaction. 
While serotonin, histamine and noradrenaline [99, 100], as well as angiotensin II and 
thromboxane A2 [101, 102] induced contractions, the application of the prostacyclin PGI2 
[101] and of vasoactive intestinal peptide (VIP) [100] induced a relaxation. 
To relay its signals a single pericyte has up to 1000 direct contact sites with adjacent 
endothelial cells [103] and therefore implicitly possesses the ability to integrate signals along 
the length of the vessel [81]. Depending on their state, pericytes also have the ability to 
secrete cytokines targeted at the endothelium in a paracrine and cell-cell contact-dependent 
manner. For example endothelin-1 produced in endothelial cells has a potent vasoconstrictive 
and mitogenic effect on pericytes [104, 105], while platelet-derived growth factor (PDGF) 
produced in pericytes controls pericyte hyperplasia and endothelial proliferation in 
angiogenesis [106].  
3.2.3. Control of angiogenesis and endothelial proliferation 
Pericytes also play an active role in the control of angiogenesis, endothelial proliferation and 
the formation of new blood vessels [71, 106-108]. Unlike the original view that initial 
endothelial tubes form without pericyte contact, and pericytes are only recruited later during 
vascular remodeling, meanwhile pericytes could be shown to be also present and to play an 
active role in the sprouting and remodeling of blood vessels [71, 109]. In a similar way 
exercise is a strong inducer of angiogenesis as an early adaptive response to eccentric 
contractions [110]. In this model it could be shown that NF-κB is activated in human skeletal 
muscle shortly following a damaging exercise and its activation primarily takes place in a 
distinct population of pericytic cells [110]. Furthermore under hypoxic conditions vascular 
endothelial growth factor (VEGF) from pericytes has the ability to simulate endothelial cells 
as well as pericytes to proliferate and migrate [111]. 
3.2.4. Reservoir cells for transdifferentiation and macrophage-like activity 
Pericytes are heterogeneous in respect to their origin [64]. In the retina they develop from 
mesoderm and neural crest, in other tissues pericytes can be recruited from bone marrow 
precursors or be generated by transdifferentiation of endothelial cells during postnatal 
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vascular repair [112-114]. Most likely all of these processes contribute to the pericyte pool, 
therefore under cell culture conditions proliferation of pre-existent pericytes as well as 
transdifferentiation from monocyte-derived macrophages are likely to contribute. 
Not only the origin of pericytes is manifold, they also themselves possess the potential to 
further transdifferentiate into a variety of cell types such as macrophage and fibroblast like 
cells [115, 116]. Therefore they have been reported recently to be a potential new cell source 
for future efforts in skeletal regenerative medicine. For this purpose the candidate growth 
factor Nell-1 could be shown to be able to induce osteogenic differentiation in pericytes 
[117]. 
In the CNS and potentially also in other tissues, pericytes are very likely to be progenitor cells 
of (brain) macrophages [116]. But already when they still can be considered pericytes they 
already show a wide range of functions generally found in macrophages. For example they 
have pinocytic and phagocytic activity from different compartments and of different kind of 
fluids [118-127]. Furthermore they express a set of macrophage markers, such as CD4, CR3 
complement, CD11b and Fc receptors [128] at least in animal experiments. In a reaction to in 
vitro stimulation with IFN-γ they react with an upregulation of MHC-II molecules on the cell 
surface [129]. They are therefore considered potential antigen presenting cells in stroke and 
vasculogenesis models [130, 131]. Nevertheless, some caution should be exercised in 
interpreting these findings since perivascular macrophages display a phenotype very similar 
to pericytes and can be easily mistaken. 
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4. microRNA can act as a fine-modulator of gene expression 
 Introduction 4.1.
MicroRNA or, shorter, miRNA are short RNA molecules with an average length of 20 – 22 
bases that are expressed in eukaryotic cells. Although they were already discovered in 1993 in 
the nematode C. elegans while studying the lin-14 gene [132] their function was only 
recognized seven years later. With let-7 in the year 2000 the second miRNA was discovered 
and found to be highly conserved among different species [133, 134]. A high level of 
conservation usually is a clear indication of vital importance for a cellular component because 
loss would have been fatal [135, 136]. 
Functionally miRNAs act as post-transcriptional regulators of gene expression by serving as 
recognition elements in a multi-enzyme complex [137]. Their target sequences can mostly be 
found in the 3’ UTR of a transcribed mRNA, but this does not always have to be the case 
[138]. If a target mRNA has been recognized it is silenced or degraded to inhibit its 
translation [137]. In humans there are estimates that more than 1000 miRNAs exist [139], that 
may have about 60% of the whole transcriptome as a target [140, 141]. This becomes possible 
since one miRNA can target hundreds or thousands of different mRNAs. miRNAs therefore 
possess the ability to induce or fine-tune whole gene programs all at once [142]. 
 Biogenesis and mode of action 4.2.
The biogenesis and maturation of miRNAs takes place in part in the nucleus and in part in the 
cytosol (for an overview see: [143]). On the genomic DNA level the majority of miRNAs is 
intergenic and transcribed independently, up to 40% is intronic. But also localization within 
an exon has been described in some cases [144]. miRNA is usually transcribed by RNA 
polymerase II [145] under control of specific promoter elements [146] into a so-called 
primary miRNA (pri-miRNA). One pri-miRNA can be the precursor to up to 6 different 
miRNAs. It is several hundred nucleotides long and includes multiple arms with an about 80 
nucleotide long RNA stem-loop on each arm [145, 147]. 
This molecule is recognized by the so called “microprocessor complex”. This complex is 
formed by a protein called “DiGeorge Syndrome Critical Region 8” (DGCR8) (Pasha in 
invertebrates) that associates with Drosha, a nuclease. In this machinery every individual 
miRNA contained in the primary miRNA is cut down to a double-stranded piece of RNA with 
a two nucleotide overhang at one side and an hairpin at the other, this is called a pre-miRNA 
[148]. The pre-miRNAs are then exported from the nucleus by Exportin 5 in a GTP dependent 
process. Exportin 5 recognizes the pre-miRNA by their overhangs [149]. 
In the cytoplasm the precursor miRNA is further processed by another nuclease called Dicer. 
Dicer cuts the loop of the molecule leaving an RNA duplex of about 22 bases length [150]. 
Although theoretically both strands can be active usually one is preferred thermodynamically 
and the other one is degraded [151-153]. The now mature miRNA is finally incorporated into 
the so-called “RNA-induced silencing complex” (RISC). RISC is a multi-enzyme complex 
containing among others Dicer and so-called Argonaute proteins (Ago). Argonaute proteins 
are essential components of the RISC. They are RNA binding proteins and responsible for the 
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correct recognition of the target sequence. Some even can directly cleave the target mRNA 
[154]. The mode and mechanism of silencing is dependent on the degree of complementarity 
between the miRNA seed sequence and the recognized mRNA. If the complementarity is 
complete the target mRNA is degraded, if the complementarity is only partial it is silenced 
[142] and further translation is blocked. 
 
Figure I-5: Schematic mechanism of the well characterized miRNA biogenesis pathway in C. elegans. 
Primary miRNA is transcribed from intronic or exonic DNA and cleaved by the protease-complex 
Drosha/Pasha. The resulting pre-miRNA is then actively exported from the nucleus by Exportin 5 and 
cleaved to the characteristic mature RNA duplex by the enzyme Dicer. It is then finally integrated into 
the so called RISC complex and serves as the template for target mRNA recognition and silencing. 
Differences in the mammalian system lie mainly in the individual enzymes. Basic structure and 
function of the pathways are analogous. (Image rearranged based upon figure 2 from [155]). 
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5. Aims of the study 
As has been presented in the previous chapters, studies on isolated pericytes have up to the 
present been mainly conducted on retinal and brain vessel pericytes. However, their role and 
functional characteristics in skeletal muscle are less clear. Their localization at the interface of 
tissue and capillaries supports the hypothesis that they play a role as sensors in the control of 
vascular tone. Therefore, a better understanding and analysis of skeletal muscle pericyte 
biology seems indispensable. Currently, this is hampered by the lack of established methods 
to isolate and cultivate pericytes from skeletal muscle. The primary goal of the present work 
was therefore to  
 establish an isolation protocol for pericytes from skeletal muscle and to 
 characterize the obtained cells with published pericyte markers from other tissues, 
but also with endothelial and smooth muscle cell markers 
Furthermore pericytes might function as sensors of tissue activity and metabolism and affect 
the vascular tone of microvessels by generation of hyperpolarizing signals and/or calcium 
waves that could be transferred to the endothelium via gap junctions. For that reason we 
aimed to 
 clarify their potential for electrical signal generation (hyperpolarization) as well as 
conduction of calcium and electrical signals in view of the fact that pericytes exert a 
role as sensors in the vascular wall 
 investigate the expression of connexins and formation of functional gap junctions of 
these cells 
Finally, as pericytes, by forming gap junctions with endothelial cells have been shown to be a 
prerequisite for the final maturation of vessels [57] we hypothesized that this process might 
involve gap junctional transfer of miRNA, thereby controlling the alteration of gene programs 
in endothelial cells. We consequently aimed to 
 analyze the potential intercellular transfer of miRNA using connexin expressing and 
non-expressing HeLa cells 
 II Materials 
1. Technical equipment 
Machine Manufacturer 
3D micromanipulator Physics Instruments, Karlsruhe 
Patch-Clamp analog-digital interface Digidata 
1200B 
Axon Instruments / Molecular Devices, 
Biberach an der Riss 
AxioVision software Zeiss, Oberkochen 
Axopatch 200A patch clamp amplifier Axon Instruments / Molecular Devices, 
Biberach an der Riss 
Bio-Photometer 6131 Eppendorf, Hamburg 
Cell counter Z2 Beckman-Coulter, Krefeld 
Cell culture centrifuge Megafuge 1.0R Heraeus Instruments, Hanau 
Cell separation system MiniMACS  Miltenyi Biotech, Bergisch Gladbach 
Clampfit software Axon Instruments / Molecular Devices, 
Biberach an der Riss 
Confocal laser scanning microscope LSM-410 Carl Zeiss, Göttingen 
Confocal laser scanning microscope TCS SP5 Leica Microsystems, Wetzlar 
ELISA plate reader Infinite F200 Tecan, Maennedorf, Switzerland 
FACS-Sort flow cytometer Beckton Dickinson, Heidelberg 
Femtojet injection system Eppendorf, Hamburg 
Floor-centrifuge RC-5B Sorvall / Thermo Scientific, Bad 
Homburg 
Flow workbench LaminAir HB2448  Heraeus Instruments, Hanau 
Fluorescence microscope Axiovert 200M Carl Zeiss, Göttingen 
Gel documentation system Doc 1000 Bio-Rad, Munich 
Gel electrophoresis apparatus Mighty Small II  Amersham Pharmacia, Freiburg 
Gel system PerfectBlue Mini-L PeqLab, Erlangen 
Humidified incubator MCO-17AI Sanyo Electric, Munich 
Inverted cell culture microscope Fluovert FU Leica Microsystems, Wetzlar 
Micropipette puller P77 Flaming/Brown Sutter Instrument, Novato, USA 
Microscopy CCD-camera for dye injection 
experiments 
Till Vision, Gräfelfing 
Office 2010 Office suite Microsoft, Unterschleißheim 
Origin data analysis software Microcal, Northhampton, USA 
pH meter PHM-82 Standard Radiometer Copenhagen, Willich 
Power supply for agarose gels PS305 Life Technologies, Darmstadt 
Power supply for SDS gels P25 Biometra, Göttingen 
SPSS 20 statistical software package IBM, Ehningen 
Steam sterilizer H&P Labortechnik, Oberschleißheim 
Thermocycler Mastercycler ep gradient S Eppendorf, Hamburg 
Tube luminometer LB9507 Berthold, Bad Wildbad 
Western Blot Imaging System ORCA-ER Hamamatsu Photonics, Herrsching 
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2. Consumables 
Article Manufacturer 
Borosilicate fiber glass tubing Hilgenberg, Maldfeld 
Buttoned cannula Braun, Melsungen 
Blotting paper Whatman / Biometra, Göttingen 
Cell culture dishes (dia. 3.5 and 10 cm) Falcon/BD, Franklin Lakes, USA 
Cell culture plates (6, 12 and 24 well) Falcon/BD, Franklin Lakes, USA 
Cell culture flasks T 25 Falcon/BD, Franklin Lakes, USA 
Cell Scraper Falcon/BD, Franklin Lakes, USA 
Cryotubes Biozym Scientific, Hessisch-Oldendorf 
Discofix-3 (three-way stopcock) Braun, Melsungen 
Disposable pipettes (5, 10 and 25 ml) Costar, Corning, USA 
Glass capillaries (unmachined) GB 100F-10 Science Products GmbH, Hofheim 
Insulin syringe BD MicroFine (U40) Becton-Dickinson, Heidelberg 
Lab-Tek chamber slides Nunc, Wiesbaden 
MiniMACS MS columns Miltenyi Biotec, Bergisch Gladbach 
Multiwell plates (24 well) Falcon/BD, Franklin Lakes, USA 
PD Tips Eppendorf, Hamburg 
96-well plates, transparent, flat bottom Corning, Amsterdam, Netherlands 
Petri dishes for bacterial culture Greiner, Frickenhausen 
Pipette tips Sarstedt, Nümbrecht 
Polystyrene round-bottom tube 5 ml Falcon/BD, Eremdodegem, Belgien 
Reaction tube 1,5 ml Eppendorf, Hamburg 
Reaction tubes 15 and 50 ml Falcon/BD, Franklin Lakes, USA 
Silicone grease, high-vacuum, heavy Wacker Chemie GmbH, München 
Silicone rubber Elastosil RT622A Wacker Chemie GmbH, München 
Slide mounts Marienfeld, Lauda-Königshofen 
Coverslips (dia. 15 mm)  Saur Laborbedarf, Reutlingen 
Surgical tools (forceps, scissors) FST fine science tools, Heidelberg 
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3. Reagents 
Substance Manufacturer 
4-Aminopyridine (4-AP) Sigma-Aldrich, Taufkirchen 
accutase Sigma-Aldrich, Taufkirchen 
Acrylamide 30% (37.5:1) Genaxxon Bioscience, Ulm 
Agarose AppliChem, Darmstadt 
Alexa 488 Invitrogen, Karlsruhe 
Ammonium persulfate (APS) Sigma-Aldrich, Taufkirchen 
Ampicillin AppliChem, Darmstadt 
Bacto-tryptone AppliChem, Darmstadt 
Bandeiraea simplecifolia lectin, TRITC 
conjugated 
Sigma-Aldrich, Taufkirchen 
BCA protein assay Pierce /Thermo, Schwerte 
Boric acid AppliChem, Darmstadt 
Bovine serum albumin Sigma-Aldrich, Taufkirchen 
Bromophenol blue Sigma-Aldrich, Taufkirchen 
BSA, fraction V, fatty acid free Boehringer-Mannheim, Mannheim 
Calcein AM Invitrogen, Karlsruhe 
Calcium-chloride, CaCl2 Merck, Darmstadt 
Chamber slides Lab-Tek Nunc / Thermo, Schwerte 
Chemiluminescence substrate ECL AppliChem, Darmstadt 
Collagen G Biochrom AG, Berlin 
Collagenase A Roche, Mannheim 
DiBAC4(3) Invitrogen, Karlsruhe 
D-MEM (Dulbecco’s modified Eagle Medium) Invitrogen, Karlsruhe 
DMSO (Dimethyl sulfoxide) AppliChem, Darmstadt 
DNA ladder, 2-log New England Biolabs, 
Frankfurt/Main 
Dual-Luciferase Reporter Assay System E1910 Promega, Mannheim 
EDTA (Ethylenediaminetetraacetic acid) AppliChem, Darmstadt 
EGTA (Ethylene glycol tetraacetic acid) Sigma-Aldrich, Taufkirchen 
Endothelial Cell Growth Medium Promocell, Heidelberg 
Ethanol AppliChem, Darmstadt 
Ethidium bromide Sigma-Aldrich, Taufkirchen 
FACS-Flow Becton-Dickinson, Heidelberg 
FCS (Fetal Calf Serum) Biochrom AG, Berlin 
Flufenamic acid Sigma-Aldrich, Taufkirchen 
Formaldehyde 37 % AppliChem, Darmstadt 
Glucose AppliChem, Darmstadt 
Glycerol AppliChem, Darmstadt 
Glycine AppliChem, Darmstadt 
Growth factor supplement Promocell, Heidelberg 
HEPES (4-(2-hydroxyethyl)-1-piperazine-ethane-
sulfonic acid) 
Sigma-Aldrich, Taufkirchen 
HiPerFect transfection reagent Qiagen, Hilden 
Hydrogen peroxide (H2O2) AppliChem, Darmstadt 
Immu-Mount mounting medium Shandon, Pittsburg, USA 
Leupeptin AppliChem, Darmstadt 
L-Glutamin Invitrogen, Karlsruhe 
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Substance Manufacturer 
LNA (N
ω
-nitro-L-arginine) Sigma-Aldrich, Taufkirchen 
Magnesium chloride, MgCl2 AppliChem, Darmstadt 
Medium 199 Invitrogen, Karlsruhe 
Methanol AppliChem, Darmstadt 
Microbeads rat-anti-mouse IgM Miltenyi Biotec, Bergisch-Gladbach 
miRNA mimics Dharmacon / Thermo, Schwerte 
N,N,N’,N’-tetramethylethylenediamine (TEMED) AppliChem, Darmstadt 
NBCS (New born calf serum) Biochrom AG, Berlin 
Nonfat dried milk powder AppliChem, Darmstadt 
NP-40 Sigma-Aldrich, Taufkirchen 
Nucleotide mix Roche, Mannheim 
PageRuler electrophoresis protein standards Fermentas, St. Leon-Rot 
PBS- / PBS+ Apotheke des Klinikums Innenstadt, 
München 
Penicillin G Sigma-Aldrich, Taufkirchen 
PKH-26 Red Fluorescent Cell Linker Kit Sigma-Aldrich, Taufkirchen 
Plasmid purification Kit NucleoBond Xtra Macherey-Nagel, Düren 
Plasmid purification Kits Mini & Maxi Qiagen, Hilden 
Potassium chloride, KCl Merck, Darmstadt 
Potassium dihydrogen phosphate, KH2PO4 Merck, Darmstadt 
Pronase E Merck, Darmstadt 
Propodium-Iodide Sigma-Aldrich, Schnelldorf 
Puromycin AppliChem, Darmstadt 
Rapid DNA ligation Kit Roche, Mannheim 
Restriction enzymes New England Biolabs, 
Frankfurt/Main 
RNAse, DNAse free Invitrogen, Karlsruhe 
siRNA resuspension buffer Qiagen, Hilden 
Sodium chloride (NaCl) AppliChem, Darmstadt 
Sodium deoxylcholate AppliChem, Darmstadt 
Sodium dihydrogen phosphate (NaH2PO4) AppliChem, Darmstadt 
Sodium dodecylsulfate (SDS) AppliChem, Darmstadt 
Sodium fluoride Merck, Darmstadt 
Sodium hydrogen carbonate (NaHCO3) Merck, Darmstadt 
Sodium hydroxide (NaOH) AppliChem, Darmstadt 
Sodium orthovanadate Alexis / Enzo Life Sciences, Lörrach 
Sodium pyrophosphate Sigma-Aldrich, Taufkirchen 
Sodium pyruvate Sigma-Aldrich, Taufkirchen 
Streptomycin Sigma-Aldrich, Taufkirchen 
SuperFect transfection reagent Qiagen, Hilden 
Superoxide dismutase (SOD) Roche, Mannheim 
Taq DNA polymerase Roche, Mannheim 
TEMED (Tetramethylethylenediamine) AppliChem, Darmstadt 
Tris Base AppliChem, Darmstadt 
Triton X-100 Sigma-Aldrich, Taufkirchen 
Trypsin-EDTA Sigma-Aldrich, Taufkirchen 
Tween 20 AppliChem, Darmstadt 
Western blot blocking reagent Roche, Mannheim 
Western-Blotting Membrane Hybond-P Amersham Pharmacia, Freiburg 
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Substance Manufacturer 
XL-1 blue competent E. coli Stratagene / Agilent, Waldbronn 
Xylene-cyanol AppliChem, Darmstadt 
Yeast extract AppliChem, Darmstadt 
β-Glycerophosphate Sigma-Aldrich, Taufkirchen 
β-Mercapto-ethanol AppliChem, Darmstadt 
 
 III Methods 
1. Mammalian cell culture 
Established cell culture techniques were used to cultivate primary hamster pericytes, 
endothelial cells as well as immortalized tumor cell lines. The cell lines used in this work are 
listed in Table III-1. 
Cell line Origin Growth Selection 
PC Primary hamster pericytes adherent - 
SMC Primary smooth muscle cells adherent - 
3G5 Antibody producing hybridoma cell line suspension - 
HUVEC Primary human umbilical vein endothelial cells adherent - 
HeLa Human cervix carcinoma adherent - 
HeLa40 HeLa stably transfected with connexin 40 adherent Puromycin 
HeLa43 HeLa stably transfected with connexin 43 adherent Puromycin 
Table III-1: Overview of the cell lines used in the current study. Respective growth conditions and 
selection antibiotics are given where applicable 
Fetal calf serum (FCS) was heat inactivated prior to use by incubation for 30 minutes at 56°C 
and subsequent frozen for storage at -20°C. All cell culture work was performed under sterile 
conditions in a laminar flow workbench. Cell growth was monitored daily under a light 
microscope. If not otherwise stated, all cell lines were kept in 10 cm plastic dishes at 37°C in 
a humidified atmosphere containing 5% CO2. They were grown up to 90% confluence and 
then split onto new dishes. For this purpose cells were first washed with calcium free 
phosphate buffered saline solution (PBS) and then treated with Trypsin-EDTA solution at 
37°C. Once the cells had detached from the culture dish, the Trypsin-reaction was stopped 
with full medium containing serum and the cells were re-plated in new culture dishes. For 
culturing of human umbilical vein endothelial cells (HUVEC) the dishes were additionally 
treated with Collagen-G (0.001% in PBS) for 30 minutes at 37°C.  
Substance Amount 
Sodium chloride (NaCl) 8.0 g 
Potassium chloride (KCl) 0.2 g 
Di-sodium hydrogen phosphate (Na2HPO4) 1.44 g 
Potassium di-hydrogen phosphate (KH2PO4) 0.24 g 
Table III-2: Contents of the phosphate buffered saline solution without calcium (PBS-). All the 
constituents were mixed in 1l of ddH2O and then the pH value adjusted to 7.4. The solution was then 
autoclaved sterile and stored at room temperature. 
For patch clamp experiments, analysis of gap junctional coupling or immunocytochemistry 
the cells were seeded on collagen coated cover slips (15 mm diameter) which were placed in 
24-well plates normally at a density of 1.5 x 10
6
 cells per well. 
Cells which could not be used immediately were regularly frozen for later use. Freezing 
pauses cells in their metabolic activity. The composition of the freezing medium can be found 
in Table III-3. DMSO acts in this medium as an antifreeze agent, interfering with the 
formation of ice crystals as the medium freezes. Therefore cells are protected when they are 
slowly frozen. When thawing the cells DMSO has to be washed out quickly to avoid damage 
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to the cells. They were therefore quickly thawed at 37°C in a water bath and then immediately 
washed in pre-warmed medium once before plating. 
HeLa and 3G5 cell line stock tubes were kept in aliquots in liquid nitrogen at -196°C. 
Pericyte, SMC and endothelial cell primary cultures were used fresh whenever possible and 
residual material stored for shorter periods of time at -80°C in a freezer or for prolonged 
storage in liquid nitrogen. 
Substance Percentage 
D-MEM 70% 
NBCS / FCS 20% 
DMSO 10% 
Table III-3: Composition of the freezing medium 
 HeLa cell culture 1.1.
HeLa wildtype (ATCC CCC2) and the connexin transfectants HeLa37, HeLa40 and HeLa43 
were a kind gift from Professor Dr. Klaus Willecke (University of Bonn). The generation of 
these cells is described in [156]. The cells were cultivated in Dulbecco’s Modified Eagle 
Medium (D-MEM) supplemented with 10% new-born calf serum (NBCS), 100 U/ml 
penicillin and 100 µg/ml streptomycin. HeLa cells stably overexpressing connexins were 
grown in the same medium additionally containing 1 µg/ml puromycin as a selection 
antibiotic. Cells were trypsinized when they reached confluence and replated in a 1:5 to 1:12 
ratio depending on experimental requirements. 
 HUVEC isolation and culture 1.2.
Human umbilical vein endothelial cells (HUVEC) were isolated according to a modified 
protocol from Jaffe et al. [157] by technical assistants. Umbilical cords were obtained from 
the department of gynecology and obstetrics of the LMU – University of Munich, Klinikum 
Grosshadern and Klinikum Innenstadt. They were stored in PBS containing calcium and 
antibiotics (Amphotericin, Puromycin and Streptomycin) to avoid contamination for a 
maximum of three days before HUVEC isolation. All buffers and culture media were pre-
warmed to 37°C in a water bath prior to usage. 
Isolated HUVEC were cultured in endothelial cell growth medium (Promocell) supplemented 
with growth factors (Table III-4) supplied by the manufacturer. Medium was changed the 
following day of isolation and cells were kept in culture until they reached confluence. In 
experiments only passages I and II were used. 
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Factor Amount 
Basic Fibroblast Growth-Factor, human, recombinant 1.0 ng / ml medium 
Endothelial cell growth supplement/Heparin 0.004 ml / ml medium 
Epidermal growth-factor, human, recombinant 0.1 ng / ml medium 
Hydrocortisone 1.0 µg / ml medium 
Phenol red 0.62 ng / ml medium 
Fetal calf-serum 0.02 ml / ml medium 
Table III-4: Growth factors supplied with the endothelial cell growth media by the manufacturer 
Promocell. They were stored in aliquots and added prior to use. 
 Smooth muscle cells (SMC) 1.3.
Human umbilical cord smooth muscle cells (SMC) were obtained commercially from 
Promocell, Heidelberg. They were cultured in high-glucose D-MEM containing 4.5 g/l 
glucose, supplemented with 20% fetal calf serum (FCS) and 1% Penicillin/Streptomycin. 
 Pericytes and 3G5 hybridoma cells 1.4.
Pericytes and 3G5 cells were cultured in D-MEM containing 1 g/l glucose. The medium was 
supplemented with 10% FCS and 1% Amphotericin/Penicillin/Streptomycin solution. The  
non-adherent mouse 3G5 hybridoma cell line (ATCC CRL 1814 [158], American Type 
Culture Collection, Manassas, VA, USA) was grown in 50 ml flasks. 
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2. Isolation of pericytes from hamster muscle 
 Surgical procedures 2.1.
Syrian gold hamsters (mesocricetus auratus) were euthanized with an overdose of 
Pentobarbital, shaved and treated with depilatory cream. The animals were then positioned on 
the stage of a microscope for the further dissection steps. 
  
Figure III-1: The thigh muscle was surgically preparated (left image) and shredded (right image) under 
a laminar flow hood to maintain aseptic conditions 
Following the incision, the thigh muscles (mainly the M. gracilis, the adductors and the M. 
quadriceps femoris) were dissected and taken out. They were then put into a glass petri dish 
and minced into small pieces under sterile conditions. The resulting now accessible muscle 
“glop” was then enzymatically digested with Collagenase A and Trypsin in PBS at 37°C for 
two hours under constant rotation. The resulting mixture was subsequently washed at 1200 
rpm for 5 min at room temperature and the supernatant discarded. The resulting pellet was 
washed once more in 5 ml D-MEM containing 10% FCS. Cells and debris were resuspended 
in 10 ml D-MEM with 10% FCS. 
  
Figure III-2: The minced and digested muscle was passed through a 100 µm mesh (left image). The 
isolated cells and debris could then be visualized directly following the isolation under a cell culture 
microscope (right image). 
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To remove large muscle particles the mixture was then passed through a 100µm mesh and 
incubated overnight in a 10cm dish (including detached cells and small capillary fragments). 
The resulting fragments were further digested with Trypsin daily for three more days. For this 
purpose the supernatant was taken off leaving only attached cells on the plate. It was then 
centrifuged at 1200 rpm for 5 minutes and the pellet resuspended in 1 ml Trypsin ( 
  
  
) and 
5 ml D-MEM + 1% FCS. This was then kept in a rotating flask for one hour at 37°C. After 
this incubation it was centrifuged again, washed and resuspended in D-MEM with 10% FCS. 
The digested cell mixture was then added back to original culture dish. 
For further growth and expansion of pericytes in cell culture they were further grown for 8 to 
14 days with culture medium replaced every 3 days. With this method between 6 and 20 
culture dishes per animal could be obtained for further purification with magnetic beads. 
 Purification of pericytes using the 3G5 antibody 2.2.
2.2.1. Background 
For the purification of pericytes from cultures of adherent cells, magnetic cell sorting (MACS, 
Miltenyi Biotec) with 3G5-coated beads was used. 3G5 is a monoclonal antibody of the IgM 
type (kappa light chain), that was originally produced in mouse by immunizing animals with 
fetal rat brain. The antibody specifically reacts with an acetylated ganglioside that can be 
found in a variety of cell types, including pancreatic islets, neurons and human T lymphocytes 
[158]. In the vasculature the antibody has been used to identify pericytes [159]. 
2.2.2. Magnetic bead cell separation 
To produce this antibody in vitro, hybridoma cells were grown in 50 ml flasks as described 
previously. Antibody containing supernatant was harvested 18 to 24 days after splitting and 
used immediately or frozen at -20°C for later use. Microbeads coated with rat anti mouse-IgM 
were mixed with 5 ml of 3G5 antibody containing supernatant for 30 minutes at 4°C. Those 
beads were then loaded onto a medium sized positive selection (type MS) column and placed 
in a MiniMACS separator as shown in Figure III-3. To purify pericytes from adherent cell 
cultures the cells were washed with PBS-, detached by treatment with accutase and loaded 
onto the separation columns. Subsequently the columns were washed three times with 
phosphate buffer at pH 6.5 (20 mM HEPES, 100 mM NaCl). For elution of 3G5 positive cells 
the columns were taken out of the magnetic field and perfused with 2 ml of full medium. The 
purified population of cells was then plated in 35 mm culture dishes and further cultivated 
until they were used in experiments. Only cells in passages 1 and 2 were used for 
experiments, higher passages were not investigated. 
24 Methods 
 
 
 
Figure III-3: Schematic representation of the Miltenyi MACS positive magnetic cell separation 
procedure (modified after: [160]). Cells were labeled with magnetic-bead coupled antibodies against 
the 3G5 epitope and then passed through a sorting column exposed to a strong magnetic field. This 
way 3G5 positive cells are held back in the column and can in the final step be eluted separately. 
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3. Cell transfection with synthetic miRNA and plasmids 
 miRNA transfections 3.1.
RNA interference was performed using synthetic double stranded miRIDIAN microRNA 
mimic oligonucleotides purchased from Dharmacon (Thermo Scientific). Additionally a non-
silencing, pre-validated control from C. elegans was utilized. These mimics were delivered 
lyophilized and upon arrival dissolved in siRNA resuspension buffer (Qiagen). The stock 
solution (20 µM) was stored in 40 µl aliquots at -20°C. miRNA transfections were performed 
with HeLa cells seeded in 6-well plates for co-culture experiments or in 12-well plates for 
morphology and cell cycle analysis. 
Name Sequence Species 
miR124 mimic 5’ UUA AGG CAC GCG GUG AAU GCC A 3’ H. sapiens 
miR15b mimic 5’ UAG CAG CAC AUC AUG GUU UAC A 3’ H. sapiens 
miRNA neg. control 5’ UCA CAA CCU CCU AGA AAG AGU AGA 3’ C. elegans 
Table III-5: Sequences and source organisms of the synthetic miRNA analoga used in the miRNA 
transfection and co-culture experiments. 
 
Culture 
plate 
format 
Volume of 
culture medium 
[µl] 
Volume of 20 µM 
siRNA stock 
solution [µl] 
Volume of 
HiPerFect 
Reagent [µl] 
Final miRNA 
concentration 
[nM] 
12-well 1100 6 6 100 
6-well 2300 12 12 100 
Table III-6: Amounts of reagents for cell transfections with miRNA. The transfection protocol was 
designed according to recommendations given by Qiagen in the HiPerFect user manual 
HeLa cells were seeded the day before the experiment to obtain a density of around 70 to 80% 
confluence on the day of transfection. For transfections miRNA was diluted in culture 
medium without serum and antibiotics to a final concentration of 100 nM (Table III-6) and 
HiPerFect transfection reagent (Qiagen) was added. The samples were then incubated for 5-10 
minutes at room temperature to allow the formation of the transfection complexes. Finally the 
miRNA transfection solution was added drop-wise onto the cells directly in the culture plates. 
No further medium change was performed during the experiments unless otherwise indicated. 
 Growth and purification of plasmids 3.2.
Plasmids for transfection were grown in chemically competent XL-1 blue coli (Stratagene) in 
standard Lysogeny Broth (LB) medium. The ingredients listed in Table III-7 were dissolved 
in 1 l of ddH2O and then autoclaved. To ensure specific growth of transformed bacteria 100 
mg/ml Ampicillin was added to the medium just before use. 
Plasmids were purified in small quantities (up to 20 µg DNA) with the QIAprep Spin 
Miniprep Kit (Qiagen). Large scale plasmid purifications (up to 500 µg DNA) were 
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performed with the Maxi Plasmid Kit (Qiagen) or with the NucleoBond Xtra Kit (Macherey-
Nagel) according to manufacturer’s instructions. 
Substance Amount 
Bacto-tryptone 10 g 
Yeast extract 5 g 
NaCl 10 g 
Table III-7: Contents of LB bacterial growth medium. 
 Transfection with expression plasmids 3.3.
For cell transfections with expression plasmids SuperFect transfection reagent (Qiagen) was 
used according manufacturer’s instructions. This reagent chemically is an activated dendrimer 
that possesses a “defined spherical architecture, with branches radiating from a central core 
and terminating at charged amino groups”3. Complexation with DNA yields a net positive 
charge that facilitates binding to negatively charged receptors on the cell surface and 
improved uptake. 
Cell transfections with plasmid DNA were carried out in 12-well plates, 6-well plates or in 
10cm dishes. Cells were seeded the day before transfection in a density that they would reach 
70-80% confluence on the next day. For HeLa cells this equaled to about 1x10
5
 cells per well 
of a 12-well plate, 2x10
5
 cells per well of a 6-well plate and 2x10
6
 cells in a 10 cm dish. 
The amounts of DNA used are given in the respective experimental chapters. If lower 
amounts of expression plasmids were needed, an empty vector pUC18 was co-transfected to 
ensure equal amounts of total DNA in all transfections. 
On the day of transfection plasmid DNA was diluted in growth medium without serum or 
antibiotics (SFM) to obtain the final volume given in Table III-8 and SuperFect transfection 
reagent (Qiagen) was added. To allow the formation of transfection complexes the samples 
were incubated for 5-10 minutes at room temperature. In the meantime the cells were washed 
once with PBS-. After the incubation time full medium containing serum and antibiotics was 
added to the transfection complexes and this mixture was then applied onto the cells. The 
cells were further cultivated for 2-3 hours under standard cell culture conditions before they 
were washed and medium replaced with regular full culture medium. 
Culture 
plate format 
DNA [µg] Final volume of 
DNA in SFM[µl] 
Volume of SuperFect 
Reagent [µl] 
Volume of full 
medium [µl] 
12-well 1.5 75 7.5 400 
6-well 2.0 100 10.0 600 
10 cm 10.0 300 60.0 3000 
Table III-8: Pipetting scheme of DNA and SuperFect reagent for transfection of adherent cells with 
expression plasmids indifferent cell culture systems. Protocol and amounts followed manufacturer’s 
instructions 
  
                                                 
3
 SuperFect transfection handbook, page 7, Qiagen 12/2002 
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4. Light microscopy of cells and tissues 
 Introduction 4.1.
Fluorescence microscopy represents a commonly used laboratory technique for visualizing 
the subcellular location of antigens that have been stained with fluorescent dyes. Depending 
on the physical characteristics of the dye and the labeled antibody, selective labeling of 
proteins, lipids and sugars can be performed. In the current study Alexa Fluor dyes 
(Invitrogen) were used [161]. These dyes exhibit a relatively high brightness and are little 
prone to photobleaching [162]. For two-color experiments, dyes with different 
excitation/emission characteristics were chosen. The staining pattern was subsequently 
visualized on a fluorescence microscope. 
 Microscopy setups 4.2.
Optical microscopy studies were performed on three different microscopes. Cell culture 
images of live cells were taken on an inverted cell culture microscope Fluovert FU (Leitz) 
with a handheld digital camera DSC-W100 (Sony). Immunofluorescence stainings of 
pericytes for Cx43, NG2, αSMA, PDGFR-β and vWF were examined on an Axiovert 200M 
fluorescence microscope (Zeiss) using a 63x/1.40 oil lens and recorded with the AxioVision 
package (Zeiss). The fluorophores were excited at 488nm and 543nm wavelength with a 
HBO100 mercury vapor lamp (Zeiss). Confocal microscopy in tissue sections was done on 
laser scanning microscope LSM-410 (Zeiss) using a Zeiss 63×/1.2 water or a Zeiss 63×/1.4 oil 
objective. In fluorescence microscopy negative controls were always analyzed in parallel. 
 Antibodies 4.3.
Antigen Species Dilution Manufacturer 
NG2 rabbit 1:50 Santa Cruz, Heidelberg 
NG2 mouse 1:50 Abcam, Cambridge, UK 
α-smooth muscle actin (αSMA) mouse 1:100 Sigma, Taufkirchen 
von Willebrand Factor (vWF) rabbit 1:100 Sigma, Taufkirchen 
Platelet derived growth factor 
receptor beta (PDGFR-β) 
rabbit 1:100 Santa Cruz, Heidelberg 
KV 1.5 rabbit 1:50 Sigma, Taufkirchen 
Connexin 43 rabbit 1:100 Sigma, Taufkirchen 
Table III-9: Overview over the primary antibodies used for immunostainings. 
 
Antigen Species Label Dilution Manufacturer 
Anti-rabbit goat Alexa Fluor 546 1:200 Invitrogen, Karlsruhe 
Anti-mouse goat Alexa Fluor 488 1:200 Invitrogen, Karlsruhe 
Table III-10: Fluorescently labeled secondary antibodies used for immunostaining and flow 
cytometry. 
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 Staining of cells from cell culture 4.4.
Immunostaining of adherent cells cultivated in cell culture was performed using Lab-Tek 
chamber slides (Nunc / Thermo Scientific). To facilitate pericyte growth these slides were 
coated with collagen G (Biochrom) prior to seeding as described before. The cells were 
subsequently incubated at standard growth conditions overnight and then fixed and stained 
with specific antibodies. 
4.4.1. Staining procedures 
As a first step slides carrying pericytes or other cells of interest were washed in PBS+ three 
times after removing the culture medium. They were then fixed in 3.7% Formaldehyde for 
10 minutes at room temperature and, if necessary, permeabilized with 0.3% Triton-X100 for 
1 minute immediately after fixation. After this step the slides were washed again three times 
with PBS+. To avoid unspecific binding of the antibodies the samples were then blocked for 
20 minutes in 1% bovine serum albumin, fraction V, fatty acid free (Sigma-Aldrich) at room 
temperature. This PBS/BSA solution was also used to dilute primary and secondary 
antibodies. Incubation with primary antibody was subsequently performed overnight at 4°C. 
Unbound antibody was then removed by washing with PBS+ and the slides incubated with the 
appropriate secondary antibody for 30 minutes at room temperature in the dark. For 
microscopy and storage the samples were covered with a cover glass in Immu-mount 
mounting medium (Shandon / Thermo Scientific). 
 Staining of muscle sections 4.5.
4.5.1. Sample preparation and staining protocol for thigh muscle 
Samples of hamster thigh muscle were embedded in paraffin and subsequently sectioned into 
5µm slices. For immunostaining the respective slides were rinsed under running cold tap 
water and deparaffinated and rehydrated using a standard xylene-ethanol protocol given in 
Table III-11. 
Reagent Time 
Xylene 2 x 3 minutes 
Xylene 1:1 with 100% ethanol 3 minutes 
100% ethanol 2 x 3 minutes 
95% ethanol 3 minutes 
70% ethanol 3 minutes 
50% ethanol 3 minutes 
Table III-11: Outline of the Xylene-ethanol procedure that is necessary to deparaffinize tissue 
samples embedded in paraffin prior to staining. 
Substance Amount 
Trypsin 50 mg 
dd H2O 10 ml 
Mix to dissolve, store at -20°C  
Table III-12: Preparation of the 0.5% Trysin buffer that was used for the enzymatic antigen retrieval in 
tissues before staining with antibodies 
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Deparaffinated slides were kept constantly in tap water step to avoid drying. Slides were then 
treated with 0.5% trypsin buffer (Table III-12) for 30 minutes at 37°C for antigen retrieval. 
Tissue samples were permeabilized with 0.3% Triton-X solution for 30 minutes and washed 
three times with PBS+. Blocking of unspecific antibody binding was performed using 1% 
BSA in PBS+. Primary antibodies were diluted in 1% BSA containing PBS+ and incubated at 
4°C overnight. Dilutions of individual antibodies are given in Table III-9. On the next day the 
slides were washed three times and then incubated with the appropriate fluorescent labeled 
secondary antibody for 1h at room-temperature at a 1:200 dilution. 
4.5.2. Sample preparation and staining protocol for cremaster muscle 
Sections from hamster cremaster muscle were prepared similarly to thigh muscle sections. 
They were embedded in paraffin and sectioned 16µm slices to allow the observation of 
longitudinal vessels. Deparaffinization and rehydration was performed as described in Table 
III-11 and for blocking endogenous peroxidase a 0.5% H2O2 in 100% methanol solution was 
added for 10 minutes. Epitope unmasking was performed by treating with 10% Pronase E 
(Merck) in Tris buffer (50 mM Tris-HCl, 5 mM EDTA at pH 7.5) for 10 minutes. The 
samples were then blocked with PBS+ containing 1% BSA and 0.025% Tween. Primary 
Antibody binding was performed in 1% BSA containing PBS+ at 4°C overnight. Antibody 
dilutions were the same as in hamster thigh muscle sections. For a better display of the vessels 
TRITC-conjugated Lectin from Bandeiraea simplicifolia (Sigma) was added together with the 
fluorescent labeled secondary antibody (1:200) for 1 hour. 
 Direct staining of cell membranes with PKH-26 4.6.
In some experiments in this thesis co-culture experiments were performed that required the 
separate analysis of the two cell populations. For this purpose a fluorescent labeling of one 
cell population with the integral membrane dye PKH-26 (Sigma, Taufkirchen) was used. 
PKH-26 offers sufficient brightness as well as stability and the staining can be performed very 
quickly using a custom adapted protocol for adherent cells, which allows the staining directly 
in 10 cm culture dishes. 
Before the staining procedure the adherent cells in a 10 cm dish were washed thoroughly three 
times with PBS- and then pre-covered with 500 µl of manufacturer supplied Diluent C. For 
preparation of the staining solution 3 µl of PKH-26 were diluted in 500 µl of diluent C, mixed 
well by gently shaking and then added on the culture plate. The cells were then incubated for 
4 – 5 minutes at 37°C in the dark. Afterwards the staining solution was aspirated and the 
reaction stopped by the addition of 1 ml of FCS. After removal of the FCS the plate was 
washed three more times with PBS- to remove residues of unbound and unstopped PKH-26 
and then used directly in the experiment. 
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5. Western Blotting 
Western blotting is a standard laboratory procedure used to transfer proteins that have 
previously been separated by one-dimensional gel electrophoresis onto a carrier membrane for 
further detection. It has originally been described by George Stark at Stanford University in 
1979 [163] and was later modified to use nitrocellulose membranes by. 
 Sample preparation 5.1.
Adherent cells were washed with PBS solution without calcium (PBS-) and detached from 
culture dishes by trypsin-EDTA (1 ml / 10cm dish) at 37°C. The cells were pelleted by 
centrifugation at 6708g for 5 minutes in a cooled centrifuge at 4°C and washed with PBS-. 
Cell lysis was performed using RIPA buffer on ice for 15 minutes. A new stock solution of 
RIPA buffer was prepared prior to each experiment with fresh addition of protease and 
phosphatase inhibitors. Sodium orthovanadate (Na3VO4) stock solution (200mM) was 
activated prior to its first usage by repeated boiling and subsequent adjustment of the pH 
value to 10.0 until the solution remained colorless and the pH was stable at 10.0. The lysed 
cells were then centrifuged again for 10 minutes at 9700g at 4°C to pellet cell debris and 
insoluble lysis products. Lysates were either used immediately or stored at -20°C for later 
analysis. 
The total protein content of the sample was quantified with a bicinchoninic acid (BCA) assay 
(Pierce) according to manufacturer’s instructions. Bivalent cuprous ions react with proteins to 
monovalent copper and this copper can be quantitatively measured by complexation with 
bicinchoninic acid through formation of a purple colored solution. Sequential dilutions of 2 
mg/ml BSA solution served as an internal calibration curve in each assay. Measurement was 
performed in duplicate using 96-well plates (Corning) and a Tecan photometer at 550 nm. 
Substance Amount 
Tris-HCl (pH 7.5) 20 mM 
NaCl 150 mM 
EDTA 1 mM 
EGTA 1 mM 
NP-40 1% 
sodium deoxycholate 1% 
sodium pyrophosphate 2.5 mM 
β-glycerophosphate 1 mM 
Na3VO4 1 mM 
Leupeptin 1 µg/ml 
Table III-13: Composition of RIPA cell lysis buffer 
Proteins have to be denatured for the antibodies to recognize their specific epitopes. This was 
accomplished by use of sodium dodecyl sulfate (SDS) and boiling at 95 – 100°C for 5 
minutes. With this procedure the secondary and tertiary structures of the proteins are 
destroyed and the epitopes become unmasked for recognition. 
Samples were therefore diluted in 4x SDS sample buffer (Table III-14), based upon the 
original Laemmli buffer recipe given in [164]. All proteins become negatively charged upon 
attachment of SDS with the size of the charge linearly dependent on the length of the protein. 
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Therefore proteins can be separated depending on their molecular weight in the SDS 
polyacrylamide gel electrophoresis (SDS-PAGE). β-Mercaptoethanol was added to reduce 
disulfide bonds within the proteins to ensure a linear configuration. 
Substance Amount 
Tris (pH 6.8) 250 nM 
SDS 8 % 
Glycerol 40 % 
Bromophenol blue 0.008 % 
β-Mercaptoethanol 20 % 
Table III-14: Composition of 4x concentrated SDS sample buffer 
 Discontinuous SDS polyacrylamide gel-electrophoresis 5.2.
The gels used in electrophoresis are hydrophilic, three-dimensional networks of hydrocarbon 
chains. In this project gels containing 12 % acrylamide suitable for separation of proteins in 
the range of 10 – 70 kDa have been used. All gels consisted of two parts: A strongly buffered 
and stable resolving gel and a weakly buffered and loose stacking gel poured on top. This 
“two-gel” approach leads to a better resolution by creating a voltage discontinuity and 
therefore concentrating the sample at the gel boundary. Since the stacking gel has very large 
pores and a low ionic strength all proteins migrate comparatively fast through this gel to the 
border with the resolving gel. They then concentrate at this thin junction and migrate together 
into the resolving where they are finally separated into clean bands. 
After mixing Acrylamide, Tris and SDS according to Table III-15 and Table III-16 the 
addition of APS and TEMED initiated gel formation. A comb was inserted and removed again 
when the gels were polymerized. 
Substance Amount 
Acryamide/bis-acrylamide 30%/0.8% 40% 
Tris pH 8.8 375 mM 
SDS 0.1% 
APS 0.05% 
TEMED 0.05% 
Table III-15: Constituents of a 12% resolving gel 
 
Substance Amount 
Acryamide/bis-acrylamide 30%/0.8% 13% 
Tris pH 8.8 125 mM 
SDS 0.1% 
APS 0.05% 
TEMED 0.1% 
Table III-16: Composition of a 4% stacking gel 
After polymerization the gel apparatus was placed in the running chamber and the buffer 
reservoirs filled with electrophoresis running buffer (Table III-17). 30 µg of protein was 
loaded onto the gel for each sample and the colored molecular weight ladder “PageRuler” 
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(Fermentas) served as a size standard. The gels were run at a current of 20 – 35 mA until 
bromophenol blue reached the lower end of the gel. 
Substance Amount 
Tris 124 mM 
Glycine 960 mM 
SDS 0.5% 
Table III-17: Compostion of the electrophoresis running buffer used for running SDS polyacrylamide 
gels 
 Semi-dry blotting 5.3.
A semi-dry electro-blotting technique was used to transfer the separated proteins onto the 
nitrocellulose membrane. To this end the gel was carefully removed from the glass plates and 
put onto the nitrocellulose membrane and a stack of blotting paper soaked in transfer buffer as 
shown in Figure III-4. Since treatment with SDS masks all the positive charges and gives 
every protein a net negative charge, they migrate towards the anode onto the blotting 
membrane. Current was limited to a maximum calculated by the following formula: 
        [  ]       [   ]     . Depending on the molecular weight of the protein of 
interest blotting time varied between one and two hours. 
Substance Amount 
Tris 50 mM 
NaCl 150 mM 
Tween 20 0.1% 
Table III-18: Composition of western blot transfer buffer 
 
 
Figure III-4: Schematic drawing of the layers used for semi-dry blotting of proteins. The acrylamide 
gel is placed on top of the transfer membrane between two stacks of buffer soaked Whatman paper. 
 Detection 5.4.
To avoid unspecific binding the membrane was incubated in 1x blocking solution (Roche) for 
one hour under constant agitation. Primary antibodies were diluted in Tris buffer containing 
0.1 % Tween (TBS-T, Table III-20) and 0.5x blocking solution. Incubations were performed 
for 2h at 37°C. Subsequently the membrane was washed three times for five minutes in TBS-
T buffer. The membrane was then incubated for one hour with horse radish peroxidase (HRP) 
conjugated secondary antibody at room temperature. Antibody binding was visualized using 
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the enhanced chemiluminescence kit (Applichem) on a Hamamatsu gel recording system and 
Wasabi imaging software. 
 
Antigen Species Dilution Manufacturer 
Connexin 37 Rabbit 1:600 Alpha diagnostics, San Antonio, USA 
Connexin 40 Rabbit 1:600 Alpha diagnostics, San Antonio, USA 
Connexin 43 Rabbit 1:1000 Sigma 
Kv 1.5 Rabbit 1:100 Sigma 
GAPDH Mouse 1:1000 Chemicon, Hampshire, UK 
Anti-rabbit HRP conjugate Goat 1:5000 Calbiochem 
Anti-mouse HRP conjugate Goat 1:5000 Calbiochem 
Table III-19: Overview of the antibodies used for western blotting 
 
Substance Amount 
Tris-HCl (pH 7.4) 50 mM 
NaCl 150 mM 
Tween-20 0.3 % 
Table III-20: Composition of Tris-buffered saline containing Tween (TBS-T). After dissolution of the 
components the pH was adjusted to 7.6 with HCl. 
 Membrane stripping and re-probing 5.5.
To ensure equal loading the membrane was stripped and re-probed with anti-GAPDH 
antibody. To this end the membrane was incubated for one hour at room temperature in the 
stripping solution shown in Table III-21. 
Substance Amount 
Glycine 0.2 M 
NaCl 0.5 M 
Table III-21: Composition of the stripping buffer for Western Blotting 
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6. Flow Cytometry 
 Principle and parameters 6.1.
Flow cytometry, sometimes better known under the generic name “FACS” is a routine 
laboratory method for the live analysis of single cells in the range of 400 nm to 40 µm. It 
allows for the rapid multi-parameter analysis of thousands of events per second [165]. The 
instrument used for the experiments in this thesis was a Becton Dickinson FACSort flow 
cytometer. All further description and technical data refer to this instrument. 
Functionally cells that are to be analyzed pushed from the sample tube through an injection 
tube. Sheath fluid then draws the cells along through the flow chamber and positions them in 
the middle of the laser beam by means of hydrodynamic focusing. 
Two light scattering parameters are measured directly without further light filtering. Forward 
scatter (FSC) is a morphological parameter that is dependent on the relative size of the cell, 
while side scatter (SSC) is measured perpendicular to the laser beam and depends on the 
relative granularity / inhomogeneity of the analyzed cell. Three additional fluorescence 
channels can be used to investigate surface markers or after permeabilization intracellular 
protein levels, cell viability, apoptosis, membrane potential or calcium levels. 
For this purpose optical filters are positioned in the light path to separate the signals emitted 
from the different fluorochromes. These fluorochromes absorb the laser light from the argon 
laser at 488 nm and emit at a specific longer wavelength. The signal is quantified with 
photomultipliers and further analyzed using CellQuest software. 
 Staining for surface antigens 6.2.
Adherent cells were initially washed with PBS- and then detached with accutase at 37°C until 
the cells were in a single cell suspension. They were then re-suspended in growth medium and 
washed once in PBS containing 1% bovine serum albumin. Fixation was performed using a 
3.7% formaldehyde solution. All centrifugation steps in this protocol were carried out at 352g 
for 3 minutes at room temperature. 
The staining protocol was based on a standard flow-cytometry protocol and adapted for 
staining of NG2. To this end the cell pellet was centrifuged and the supernatant decanted. In 
the residual volume of approximately 100 µl the cells were incubated with 4 µl of anti-NG2 
antibody (Abcam) for 45 minutes at room temperature followed by washing twice in a 
PBS/BSA solution. 4 µl of an Alexa-Fluor 488 conjugated goat anti mouse secondary 
antibody (Table III-10) was then added and incubated for additional 30 minutes at room 
temperature. After one more washing step 5000 cells were analyzed on the flow cytometer. 
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 Sorting of fluorescently labeled cells for miRNA analysis in co-cultures 6.3.
In a part of the study co-culture experiments were necessary to analyze the potential direct 
transfer of miRNA from one cell to an adjacent cell via gap junctions. Therefore a method 
was needed to analyze the cells separately after the co-culture to avoid the inclusion of donor 
cells in the measurements. For this purpose the FACSort flow is equipped with a mechanical 
sorting unit that can operate in three different modes of purity. All experiments were 
performed with the purity set to “exclusion”. The sort rate was manually adjusted with the 
feed pressure to be around 300 events/second. 
The co-culture protocol itself is described in detail in chapter III10. Briefly, at the start of the 
co-culture experiment the miRNA acceptor cells were labeled with the red fluorescent dye 
PKH-26 as described on page 29 and plated with miRNA transfected donor cells in 6-well 
plates. After 2 days of co-culture they were harvested, pelleted in a 50 ml centrifuge tube at 
1500rpm for 7 minutes, resuspended in PBS- and then directly subjected to flow-assisted cell 
sorting. Gating was set on cells with positive fluorescence for PKH-26 in the FL-2 channel of 
the flow cytometer. 10.000 events were stored on the computer and an average of around 
70.000 acceptor cells identified, isolated and collected. Re-analysis for PKH-26 positive cells 
from the sorted population indicated a purity of the isolated cells in excess of 98% as shown 
in Figure III-5. 
 
Figure III-5: Flow cytometry dot plots of the green (FL-1) and the red (FL-2) fluorescence channel. 
Before cell sorting (left) donor and acceptor cells form two clearly distinguishable populations. In a 
second measurement after cell sorting only the upper, PKH-26 labeled target cell population can be 
seen (right). 
Sorted cells were collected in 50 ml tubes coated with BSA by short rinsing with 0.1% BSA 
solution prior to use. Following the sort cells were pelleted in a table top centrifuge at 
1200rpm for 7 minutes and lysed immediately in 150 µl of passive lysis buffer for luciferase 
measurements as described in chapter 11. 
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 Cell cycle measurements 6.4.
6.4.1. Background and methodology 
Cell cycle describes the series of events in the life cycle of a eukaryotic cell. Depending on 
the cellular growth state the cell cycle can be divided into different phases leading to division 
and proliferation of the cell [166]. Measurement of the current cell cycle phase of a cell is 
based on quantifying the cellular DNA content. This is accomplished by staining nucleic acids 
with propidium iodide (PI) followed by flow cytometry. PI is a DNA binding dye which 
shows a greatly increased fluorescence upon binding to double stranded nucleic acids. 
Therefore there is a linear correlation between cellular DNA content and emitted 
fluorescence. 
Cells whose cell cycle is currently in the G0 or G1 phase possess a diploid set of 
chromosomes and therefore emit a certain amount of fluorescence. To be able to enter mitosis 
the whole cellular genome has to be duplicated in the S phase. This leads to an increase in 
fluorescence in flow cytometry. At the beginning of the G2 phase the cell has accumulated a 
double, tetraploid set of chromosomes and PI fluorescence is therefore doubled compared to 
resting cells in G0/G1 phase. 
 
Figure III-6: Histogram of a flow cytometric DNA content measurement. Staining intensity with 
propidium iodide is directly prportional to the cellular DNA content and can therefore be used as a 
marker for the cell cycle stage distribution in the cell culture. image source: 4 
A common source of error in this method is caused by two or more cells sticking together in 
so called doublets or triplets. Two cells containing only a single set of chromosomes show up 
in the flow cytometer with a fluorescence signal equal to a single cell in G2 phase. To be able 
to detect and exclude this error it is possible to further analyze the electrical pulse generated 
in the photomultiplier tube. Signal area correlates with DNA content and signal width with the 
size of the cell or cell aggregate respectively. Therefore stepwise increases in signal width 
signify an aggregate of multiple cells and can be excluded from further analysis. 
                                                 
4
 http://www.phnxflow.com/MultiCycle.stand.alone.html, retrieved on 19.04.2012 
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Figure III-7: Parameters measured on the PMT pulse in a flow cytometer 
6.4.2. Experimental procedures 
For cell cycle measurements cells were washed with PBS - and detached from the culture 
plate with trypsin until the cells were in a single cell solution. Detachment was stopped using 
full medium and the cells pelleted by centrifugation at 1200 rpm for 5 minutes. Subsequently, 
the supernatant was removed by aspiration and the pellet resuspended in 200 µl PBS -. For 
fixation and permeabilization the cells were then transferred into 5 ml FACS tubes containing 
4 ml of ice-cold 70 % ethanol and incubated over-night at 4°C to help resolving sub-G1 
peaks. 
On the next day all the cells were pelleted at 1500 rpm for 3 minutes and resuspended in 
300 µl of PI mastermix. Following 30 minutes incubation at 37°C, DNA content could be 
quantified directly in the flow-cytometer. FSC and SSC were used to distinguish cells from 
debris and a second gate was set onto single cells as described above. Percentages of cells in 
each phase were calculated by defining regions in a FL2 histogram. 
Substance Stock solution PI master mix 
Propidium Iodide 1 mg/ml 40 µl 
RNase A 100 µg/ml 10 µl 
PBS- 1x 950 µl 
Table III-22: Preparation of PI staining buffer for cell cycle analysis. Propidium Iodide is a fluorescent 
DNA binding dye, RNAse A was added to degrade any leftover RNA to exclude co-quantification of 
RNA.  
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7. Patch clamp analysis 
Patch clamp analysis was kindly performed in the lab of Prof. Dr. Wolfram Nagel, 
Physiology, LMU Munich. 
 Introduction 7.1.
Patch clamp analysis is a technique to study the properties of membrane channels in cells. It 
was developed by Erwin Neher and Bert Sakmann and quickly became an indispensable tool. 
Both scientists received the Nobel Prize in Physiology in 1991. Patch clamping can be used in 
a variety of ways depending on the scientific approach. In whole cell patch clamping, multiple 
membrane channels are measured simultaneously over the membrane of the whole cell 
(Figure III-8). 
 
Figure III-8: Principle of patch clamping in whole cell mode. The pipette tip is lowered to the cell 
surface until it has contact with the membrane. The cell membrane within the area covered by the 
electrode is then broken by gentle suction and the electrical connection formed. 
 Experimental procedures 7.2.
Patch clamping was used to analyze the membrane channel composition of hamster skeletal 
muscle pericytes. The dependency of the current on an applied voltage or changing ion 
concentrations as well as changes of the current induced by pharmacological treatment of the 
cells allowed drawing conclusions on the underlying channel ion specificity and type. 
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Primary pericytes were used 2 to 4 days after final selection and cells were seeded on the 
glass bottom of a custom made chamber. The setup was mounted on the stage of a Zeiss 
Axiovert MXX inverted microscope. Movement of micropipettes was performed using a 
piezo driven 3D micromanipulator. Micropipettes were prepared from borosilicate fiber glass 
tubing on a Sutter P77 puller and subsequently fire polished. Electrodes were filled with 
current conducting solution (Table III-23) and input resistance was in the range of 2 to 4 MΩ. 
Whole cell recordings were made with an Axopatch 200A patch clamp amplifier and its 
output was digitized with a Digidata 1200B AD-interface under control of the PC software 
PClamp 9.0. I/V relations were plotted using Clampfit and exported to Origin for further 
evaluation. By definition currents are measured from inside to outside, therefore “outward 
currents” are positive currents. Both, a flow of positively charged ions from the inside to the 
outside or equally of negative ions from the outside to the inside is termed an outward current. 
Amount Substance 
120 mM K-gluconate 
5 mM EGTA 
2 mM MgCl2 
10 mM HEPES (pH 7.2) 
4 mM Na-ATP 
Table III-23: Cellular pipette solution used for whole cell patch clamping 
Experimentally a glass micropipette with an open tip was lowered onto the cell membrane 
under continuous control of resistance and capacitance, while a second, neutral electrode was 
placed in the culture bath. An increase of resistance indicated contact to the membrane. By 
suction a so called “gigaseal” was formed. In the next step the integrity of the cell membrane 
was broken by repeatedly applying low pressure through gentle suction and the electrode had 
a direct connection to the intracellular space. Establishment of the patch was indicated by a 
drop in resistance to values around 100 MΩ and an increase of capacitance to the value of the 
whole cell. Voltage and current across a biological membrane is primarily determined by the 
composition of the ion-channels set in the membrane. Either voltage or current can be kept 
unchanged while the respective other parameter is measured. 
Measurements of the resting potential were conducted without sending current through the 
cell after adjusting the current flow to zero. Stimulation experiments always started with cells 
clamped at the resting potential and voltages were altered stepwise in 10 mV increments. 
Measurements were taken in the -120 mV to +70 mV range for a time of 100 to 200 ms. I/V 
diagrams always depict steady state currents. 
Ion channel inhibitors and varying concentrations of potassium were used to further 
investigate the electrophysiological characteristics of the cellular ion channels. To apply the 
pharmacological agents the experimental bath (volume ~ 0.5 ml) was continuously superfused 
at a rate of 2 ml/min. In some experiments the chloride ions in PBS were substituted by 
gluconate on an equimolar basis. Three different substances were used to pharmacologically 
modulate potassium channel activity in the isolated cells: Flufenamic acid (FFA), 4-
aminopyridine (4-AP) and tetraethylammonium (TEA). Respective chemical properties and 
structures are shown in Table III-24 and Figure III-9. 
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Tetraethylammonium (TEA) 
 
4-Aminopyridine (4-AP) 
 
Flufenamic acid (FFA) 
Figure III-9: Chemical structures of the potassium channel modulating agents. Source of all images: 5 
 
Substance Action Target Conc. range IC50 
4-AP Inhibitor Voltage dependent K
+ 
channels 
0.1 – 5 mM 288 µM in Hek2936 
537 µM in CHO
7
 
290 µM in MEL [167] 
TEA Inhibitor Unsel. K
+  
channels 10 mM 330 µM in MEL [167] 
FFA Activator K
+
 channels 10 – 300 µM No data available 
 Inhibitor Ca
++
 activated Cl
-
 
channels 
 7 µM in adipocytes [168] 
28 µM in oocytes [169] 
Table III-24: Substances used to pharmacologically modulate K+ channels (All supplied by Sigma). 
  
                                                 
5
 Wikipedia, all images are in the public domain 
6
 Chantest cell line data sheet, available online: http://www.chantest.com/media/cms/pdf/spec_CT6138.pdf 
7
 Chantest cell line data sheet, available online: http://www.chantest.com/media/cms/pdf/spec_CT6137.pdf 
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8. Quantification of gap junctional communication 
 Dye injection assay 8.1.
Gap junctions represent channels between the cytoplasm of two adjacent cells. They allow for 
the free diffusion of small molecules up to around 1 kD size [41-45]. Therefore gap junctional 
coupling can be analyzed in vitro by injection of small molecular fluorescent dyes and 
subsequent monitoring of the spreading of the fluorescence signal to neighboring cells. For 
the current study the dye Alexa Fluor 488 was used at 3.5 mM concentration adapted from a 
protocol from Kameritsch et al [170]. 
 
Figure III-10: Principle of a dye injection assay to analyze gap junctional coupling. (A) before start of 
the experiment, (B) injected cell is stained with Alexa 488, (C) spreading of the dye to adjacent cells  
To analyze cell to cell communication co-cultures of HUVECs and pericytes were plated on 
collagen coated glass cover slides. To be able to definitely distinguish the two co-cultured cell 
populations HUVEC were labeled with the red lipophilic membrane dye PKH-26. Prior to the 
measurement the cells were incubated for 10 minutes in HEPES buffer containing N
ω
-nitro-L-
arginine (LNA, 30µM) to inhibit the endogenous NO-formation and superoxide dismutase 
(SOD, 50 – 500 U/ml) to eliminate superoxide anions. This treatment was used to achieve 
controlled starting conditions since both, NO and superoxide anions have been shown before 
to affect gap junctional communication [170-172]. 
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Substance Amount 
NaCl 125 mM 
KCl 3 mM 
NaH2PO4 1.25 mM 
CaCl2 2.5 mM 
MgCl 1.5 mM 
Glucose 10 mM 
HEPES, pH 7.4 10 mM 
Table III-25: Contents of HEPES buffered saline solution 
All injections were performed using the Femtojet injection system from Eppendorf in a 
custom made chamber on a heated microscope stage. Alexa Fluor 488 was injected using a 
dye filled micropipette at a tip pressure of 80 mmHg with injection duration of 0.5 s. 
Subsequently the fluorescence signals were recorded for 10 minutes after injection with a 
CCD camera (Till Vision, Gräfelfing). The absolute number of fluorescent cells after injection 
was taken as a quantitative measure for gap junctional coupling. 
 “Parachute” dye transfer assay 8.2.
As a second means of quantifying gap junctional coupling between HUVEC and pericytes a 
so called parachute assay for flow cytometry was used. In this assay, as shown in Figure 
III-11, 100% confluent donor cells were pre-labeled in green with a 500 nM Calcein-AM 
solution for 30 minutes at 37°C. After very thorough washing, which is crucial to avoid 
background staining by remaining Calcein-AM, the cells were placed back in culture medium 
and “parachuted” with red fluorescent PKH-26 labeled acceptor cells. At certain time points 
cells were then trypsinized into a single cell solution and analyzed on a BD FACScan flow 
cytometer for red and green fluorescence. The FACScan flow cytometer is identical to the 
FACSort in the optical path, filter characteristics and detectors with the only exception being 
the absence of the sorting unit. Red acceptor cells can only acquire green fluorescence if they 
are coupled to donor cells via open gap junctions and take up the dye this way. Therefore the 
percentage of double positive cells and the mean green fluorescence of PKH-26 positive cells 
allow the quantitative analysis of gap junctional communication. 
 
 
Figure III-11: Principle of the parachute dye transfer assay. HUVEC were fluorescently labelled with 
the dye Calcein-AM, which is intracellularly hydrolysed and therefore trapped intracellularly (left). 
Pericytes that were labeled with the red fluorescent membrane dye PKH-26 were then added 
(middle) and the percentage of double positive cells evaluated in flow cytometry (right).  
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9. Optical membrane potential measurements 
 Background 9.1.
Optical membrane potential measurements were performed as a functional assay for the 
conduction of a hyperpolarization from pericytes to endothelial cells. Functionally the 
fluorescent dye DiBAC4(3) (Bis[1,3-dibutylbarbituric acid]trimethine oxonol). DiBAC4(3) is 
a membrane potential sensitive indicator, that enters depolarized cells and binds to 
intracellular proteins and membranes. Upon binding fluorescence is enhanced and a red-shift 
can be observed. Depolarization of the cellular membrane increases the influx of DiBAC4(3) 
and therefore leads to a stronger fluorescence signal. Since DiBAC4(3) is negatively charged 
it is not taken up by mitochondria and therefore not susceptible to mitochondrial interference. 
It has excitation optimum around 480 nm and emits preferentially at 505 nm. The method 
applied in this thesis has been described before [173, 174] and is now performed with minor 
modifications. 
 
Figure III-12: Chemical structure of DiBAC4(3) (Image source: 
8) 
 Experimental procedures 9.2.
Optical membrane potential measurements were performed on a computer-controlled 
microscope setup (Till Photonics). Excitation was provided by a monochromator from a 
Xenon lamp at 480 nm wavelength and emission was detected at 505 nm with a cooled CCD 
camera. The setup was mounted on an inverted microscope Axiovert S100 (Zeiss). 
For each experiment co-cultures containing PKH-26 labeled HUVEC and unlabeled pericytes 
were incubated for 20 minutes with HEPES containing SOD/LNA and 4µM DiBAC4(3). 10 
seconds after starting the measurement 300 µM flufenamic acid was added to calculate the 
magnitude of the effect. Under these conditions reduced fluorescence indicated a 
depolarization of the cell membrane. 
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10. miRNA co-culture assay 
10.1.1. Overview over the experimental model 
For the quantification of miRNA transfer HeLa cells served as a model system that allowed a 
comparison of the presence and absence of gap junctional coupling between cells. Wildtype 
HeLa cells do not express connexins and therefore are communication deficient, whereas 
stable transfectants with connexin 43 regain this feature. This way a system comprising donor 
cells transfected with miR124 and acceptor cells containing a miR124 specific detection 
system could be established under coupled and under control conditions (Figure III-14). The 
miR124 sensitive detection system was constructed by inserting a miR124 specific 
recognition site in the 3’ UTR of an established luciferase expression vector. The amount of 
luciferase protein synthesized and consequently also the amount of light generated therefore is 
inversely proportional to the amount of miR124 present in the acceptor cell (Figure III-13). 
 
Figure III-13: Assay principle of the luciferase system to quantify the amount of miR124 activity in 
vitro. Under control conditions luciferase mRNA is transcribed from the vector construct in 
transfected acceptor cells and then translated unhindered into luciferase protein. The activity of this 
enzyme can be quantified by measuring the amount of emmited light (top panel). If miR124 is 
present it can recognize a specific binding site in the 3’ UTR of the luciferase mRNA and through this 
induce translational silencing leading to reduced light emmission (bottom panel). 
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Figure III-14: Experimental design of the co-culture experiments. Donor cells containing miR124 are 
co-cultured with acceptor cells that have been transfected with a miR124 sensitive luciferase 
reporter construct. If no gap jucntional transfer of the miRNA is possible a strong luminescence signal 
can be detected in the luminometer (left panel). If in contrast miR124 is transferred from donor to 
acceptor cells via gap junctions the signal intensity is attenuated (right panel). 
 
10.1.2. Detector vector constructs 
The miRNA detection constructs were generated using the commercially available vector 
pIS2 that was obtained from the Addgene plasmid repository (#12177). It was originally 
derived from pRL-SV40 by adding additional cloning sites. As shown in Figure III-15 the 
plasmid contains a Renilla luciferase reporter driven by the SV40 early enhancer/promoter. 
To render the luciferase expression sensitive to miRNA, a dimeric, fully synthetic miRNA 
recognition site was inserted via SacI and XbaI restriction digestion followed by T4 ligation at 
the site indicated in Figure III-15. 
 
     CTG GCA TTC ACC GCG TGC CTT ATG GCA TTC ACC GCG TGC CTT AT 
TCGA GAC CGT AAG TGG CGC ACG GAA TAC CGT AAG TGG CGC ACG GAA TA GATC 
 
 
Figure III-15: Structural elements of the pIS2 vector with the sequence of the synthetic miR124 
recognition dimer inserted between the SacI and XbaI restriction sites in the 3’ UTR of the luciferase 
gene (luc+). 
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To normalize for cell number variations and inconstant transfection efficiencies a second 
luciferase plasmid, pGL3 control that drives the constitutive expression of firefly luciferase 
under an SV40 promoter was always co-transfected. 
10.1.3. Experimental procedures for co-cultures with miR124 with FACS sorting 
HeLa wildtype and HeLa43 cells were split into 6-well plates on the day before transfection. 
On the next day donor cells were transfected with 100 nM synthetic miR124 mimic 
(Dharmacon) according to the amounts given in Table III-26. In parallel the acceptor cells 
were stained fluorescently with PKH-26. The cells were subsequently left in the incubator for 
two hours and then very thoroughly washed with PBS. All cells were detached from their 
culture dishes by treatment with accutase and washed by centrifuging at 1500 rpm for 7 
minutes in a table-top centrifuge. After resuspension in full medium the cell number was 
determined in a Neubauer counting chamber. Co-cultures were mixed in a 3:1 to a 5:1 donor 
to acceptor cell ratio and plated at 70 – 80 % confluency into 6-well plates. On the next day 
the whole co-culture was transfected with the detection plasmids as shown in Table III-27. 
Details on the transfection protocol are given in chapter III3. 48 hours after putting the cells in 
co-culture, they were detached with accutase as a single cell solution and subjected to flow 
cytometric cell sorting as described in chapter 6.3. Following this procedure purified acceptor 
cells were obtained strongly diluted in FACS sheath fluid and therefore pelleted at 1700rmp 
for 7 minutes in a table-top centrifuge. The cells were lysed directly in passive lysis buffer 
(Promega) and luciferase activity measurements taken immediately in a luminometer 
(Berthold Instruments). 
Substance Amount 
Serum free medium 88 µl 
Synthetic miRNA (20µM stock) 12 µl 
  
HiPerFect reagent 12 µl 
Table III-26: Amounts of the reagents for a 100nM transfection with miRNA in one 6-well 
 
Substance Amount 
pGL3 control plasmid 7.5 ng 
pIS2 Di-124 3 ng 
pUC18 1 µg 
Table III-27: Amounts of the detection plasmids used to transfect a 6-well for the co-culture 
experiment 
10.1.4. Experiments without cell sorting including mutated detection plasmids 
Further experiments were performed to experimentally verify the transfer of miRNA through 
gap junctions in a modified system with additional controls. As a second miRNA, miR15b 
was chosen. miR15b potentially plays an important role in vascular biology through the 
regulation of VEGF expression [175, 176]. 
The co-culture protocol was furthermore modified to be performed without the flow 
cytometric sorting step. As a supplementary control, three bases in the seed recognition 
sequence were mutated, similar to the methodology used in [177] in order to inhibit the 
miRNA binding. The sequences of the wild-type and respective modified binding dimers are 
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given in Table III-29. Cell numbers were strictly standardized in all experiments using an 
automated cell counter (Beckman Coulter Z2). 
On the day before transfection 10
6
 cells were plated in a 10 cm dish to serve as acceptor cells 
and 200,000 cells per 6-well were seeded as donor cells. On the following day, acceptor cells 
were transfected directly in the 10 cm culture dishes with the miR15b detection plasmids pIS2 
in the amounts given in Table III-28. Transfections with the mutated miR124 detection 
plasmid were performed according to Table III-27 in 10 cm culture dishes and scaled up by 
the factor 8, compensating for the difference in culture dish area. Simultaneously donor cells 
were transfected with either 100 nM synthetic miRNA mimic or miRNA negative control 
(Dharmacon) in the 6-well plates (amounts are given in Table III-26). All cultures were 
incubated for 1 h with the transfection solution and then washed thoroughly three times with 
PBS-. To allow for the uptake of residual transfection solution into the cells, cell cultures 
were left in the incubator for two to three additional hours. Cells were then detached with 
accutase and counted in an automated cell counter (Beckman-Coulter Z2). 125.000 cells were 
put in co-culture in 24-well plates in a 5:1 ratio for 48 hours. Following this incubation cells 
were washed in PBS- and lysed directly in the culture plate by addition of 1x passive lysis 
buffer (PLB, Promega). All experiments were performed in triplicates and means calculated 
for further evaluation. 
Substance Amount 
pGL3 control plasmid 200 ng 
pIS2-miR15b 1 µg 
pUC18 5 µg 
Table III-28: Amounts of the detection plasmids used in the miR15b experiments for transfection in 
10 cm culture dishes. 
 
miR124 target dimer with seed recognition sequence mutations 
     CTG GCA TTC ACC GCG Tcg gTT ATG GCA TTC ACC GCG Tcg gTT AT 
TCGA GAC CGT AAG TGG CGC Agc cAA TAC CGT AAG TGG CGC Agc cAA TA GATC 
Native miR15b target dimer 
     CTT GTA AAC CAT GAT GTG CTG CTA TTG TAA ACC ATG ATG TGC TGC TAT 
TCGA GAA CAT TTG GTA CTA CAC GAC GAT AAC ATT TGG TAC TAC ACG ACG ATA GATC 
miR15b target dimer with seed recognition sequence mutations 
     CTT GTA AAC CAT GAT GTG aTc CcA TTG TAA ACC ATG ATG TGa TcC cAT 
TCGA GAA CAT TTG GTA CTA CAC tAg GgT AAC ATT TGG TAC TAC Act AgG gTA GATC 
Table III-29: Sequences for the miR15b vector inserts and the 3-5 mutated miR124 dimer. In the top 
panel the native miR15b target dimer sequence is shown, in the lower two panels the three 
mutations in the seed recognition sequence are given in lower case for the miR15b and miR124 
target dimers 
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11. Luciferase gene expression assay 
 Background 11.1.
Luciferase reporter gene activity was quantified with a Dual-Luciferase Assay kit (Promega). 
In this system two individual reporter luciferase proteins are expressed and they can be 
quantified in subsequent reactions. This allows for the use of an internal control that provides 
a baseline for the normalization of experimental data for factors such as transfection 
efficiency, cell number, growth characteristics and cell lysis efficiency. 
In the assay used in this thesis firefly (Photinus pyralis) and Renilla (Renilla reniformis) 
luciferases coded on two different plasmids were used. These two enzymes have distinct 
evolutionary backgrounds and therefore developed different substrate and co-factor 
requirements. In vitro they can be measured sequentially from a single tube by quenching 
firefly luciferase luminescence before adding the specific Renilla luciferase substrates. 
 Experimental procedures 11.2.
Passive lysis using the supplied passive lysis buffer (PLB) was either performed directly in 
the plates for transfected cells or within the 50 ml collection tubes obtained in FACS sorting. 
The manufacturer’s protocol was modified to use only half the amount of reagents. 
For this purpose a 5x stock solution of PLB was diluted with distilled water by adding 1 
volume of PLB to 4 volumes of water. For each well 500 µl of 1x PLB was prepared. Cells 
were then washed once in PBS- and 500 µl of 1x PLB was added. The plate was then placed 
on an orbital shaker for 15 minutes at room temperature to allow for complete cell lysis. 
Meanwhile the luciferase assay substrate LAR II was thawed from -80°C stocks and 50 µl of 
Stop&Glo solution prepared from the manufacturer provided 50x stock solution by diluting 
with the supplied Stop&Glo buffer. 
50 µl of LAR II was pre-dispensed into luminometer tubes and 10 µl of cell lysate added by 
pipetting directly into the liquid. Firefly luminescence was then quantified in a Berthold 
LB9507 tube luminometer with a 10s measurement time. Subsequently 50 µl of 1x Stop&Glo 
solution was added and Renilla luminescence quantified for another 10 s. Finally Renilla 
readings were normalized to firefly luminescence. 
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12. Statistical analysis 
Data were collected and organized in Microsoft Excel spreadsheets. Summary files containing 
means of all experimental data were assembled to facilitate graphing and statistical evaluation 
of the data. For statistical computing the corresponding data was imported and analyzed using 
the statistics package SPSS 20 (IBM). In all experiments error probabilities (p-values) smaller 
than 0.05 were considered significant. Graphs were created either in Excel 2010 (Microsoft), 
Sigmaplot 8.0 (Systat Software) or Origin (Microcal). The tests used and the resulting p-
values are additionally mentioned in the respective figure legends. 
Differences between the distributions in the experiments on the spreading of a calcium wave 
from HUVEC to pericytes (chapter IV4.3) were analyzed with the nonparametric Kruskal-
Wallis test for independent samples. A previous Kolmogorov-Smirnov test did not yield 
normal distribution of the data. 
The differences between the treatment groups for cell cycle analysis (chapter IV5.2) were 
examined using a Wilcoxon matched-pair signed ranks test since for small sample sizes it is 
not possible to test adequately for normal distribution. 
Data on the time course of the transfer of the small molecular weight dye calcein (chapter 
IV5.3) were analyzed with the SPSS module for univariate general linear model analysis. This 
statistical tool allows performing the analysis of variance (ANOVA) for experiments with two 
or more factors. This way the differences over the time course and the differences between the 
different groups could be considered. 
The data on miRNA transfer through gap junctions experiments using miR124 and cell 
sorting was evaluated a Wilcoxon matched-pair signed-rank test, following normalization of 
the data to the not co-cultured control (chapter IV5.5.1). In these experiments due to the low 
sample number normal distribution could not be assumed. 
In the miR15b experiments (chapter IV5.5.2) a paired samples Wilcoxon signed ranks test 
was used since the underlying data were shown not to be normally distributed according to the 
Kolmogorov-Smirnov test. 
 
 IV Results 
1. Isolation of cells showing a pericyte-like phenotype 
 Growth characteristics and cell morphology 1.1.
Isolated and purified cells showed a characteristic pericyte-like morphology, consistent with 
previous reports on pericytes. The direct comparison with human umbilical vein endothelial 
cells (HUVEC) and smooth muscle cells (SMC) showed distinct morphological differences 
and clearly delineated those cell populations. As depicted in Figure IV-1 they had an irregular 
shape with long processes protruding from large and flat cell bodies. Their size was 
approximately 150 x 100 µm, although long extensions from the cell body could extend even 
further. 
 
Figure IV-1: Morphology of a hamster skeletal muscle pericyte at day 15 in cell culture showing the 
typical flat cell soma and long extending protrusions (arrows). 
 Pericyte medium selectively supports pericyte growth 1.2.
To analyze the selecting effect of pericyte culture medium, primary pericyte cultures, 
HUVEC and porcine arterial endothelial cells (PAEC) were grown in pericyte medium for 
two weeks. Images were recorded on days 0, 7 and 14 to analyze changes in cell morphology. 
As is shown below this medium favors the selective growth of pericytes over endothelial 
cells. Interestingly, HUVEC and PAEC cultures also seem to contain a small amount of 
pericytes that survive in these cultures, when the endothelial cells have already died. 
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Primary hamster culture in pericyte medium 
day 0 day 7 day 14 
HUVEC in pericyte medium 
day 0 day 7 day 14 
PAEC in pericyte medium 
day 0 day 7 day 14 
Figure IV-2: Representative images of a primary hamster pericyte (top), HUVEC (middle) and PAEC 
(bottom) culture at days 0, 7 and 14 grown in pericyte medium. Pericyte medium selectively 
promotes the growth of pericytes over endothelial cells in mixed  cultures on days 7 and 14. 
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 Expression of pericyte markers 1.3.
The isolated and bead-isolated cells were analyzed for the expression of typical pericyte 
markers after 16 – 30 days in culture in passage one or two. For this purpose three different 
methods were used to demonstrate the expression of previously published pericyte markers in 
the isolated cells. In this respect western blotting served as a sensitive way to detect marker-
proteins in whole cell lysates, while immunofluorescence staining yielded data on the (sub-) 
cellular localization and flow-cytometry allowed the co-analysis of multiple markers on the 
single cell level. Since there seems to be no single and universally accepted pericyte marker, a 
panel of markers was selected to characterize the cells. 
1.3.1. Qualitative analysis: Western Blotting 
Detection of the marker antigens in cell lysates of HUVEC, SMC and PC was performed 
using western blot analysis. Data from a representative experiment are shown. HUVEC and 
SMC served as controls for the most probable cellular contamination in the culture. While 
pericytes stained positive for αSMA, NG2 and PDGFR-β, they were negative for vWF 
(Figure IV-3). vWF is an essential endothelial protein and accordingly was found to be 
present in HUVEC. SMC and pericyte cultures were negative for vWF (n=3 independent cell 
cultures, the unspecific dot in the SMC lane was present only in the blot shown and is of 
unknown origin). Data from a representative experiment is shown (Figure IV-3). 
 
Figure IV-3: Western Blot analysis for the expression of pericyte markers. The isolated pericytes 
express the typical pericyte marker proteins PDGFR-β, NG2 and αSMA. HUVEC and SMC were used as 
controls. Images depict typical results as observed in 3 independent cell cultures. 
1.3.2. Analysis of pericytic markers in immunofluorescence staining 
To further characterize the pericytic phenotype of single cells in culture, immuno-
cytochemical double-staining with specific antibodies was performed. NG2, αSMA and 
PDGFR-β have been described in detail in the previous chapter. In our cultures about 80-90% 
of the cells stained double positive for NG2 and αSMA or double positive for αSMA and 
PDGFR-β (Figure IV-4; n=4 independent cell cultures each). In contrast, no staining was 
detectable with the endothelial cell marker von Willebrand factor (vWF) while HUVEC as 
endothelial controls stained positive for vWF.  
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Figure IV-4: Representative images showing positive staining of pericytes in culture for the 
established pericyte markers NG2 and PDGFR-β (Top and middle panels, n=4, representative images 
shown). On the lower panel pericytes show no staining for the endothelial marker vWF (n=4, 
representative image shown). 
1.3.3. Quantitative analysis: Flow cytometry 
To obtain a more precise quantitative estimate of the pericyte content in the purified and 
selectively grown cultures, five cultures were additionally analyzed for NG2 expression in 
flow cytometry. In accordance with estimates from immunocytochemistry, this analysis 
indicated a mean percentage of NG2 positive cells of 81% ± 4.7% (mean ± SD). 
Results 55 
 
 
Figure IV-5: Quantitative analysis of NG2 expression in five individual pericyte cell preparations using 
flow cytometry. On average 81 % of the cells in the total population were positive for NG2 (horizontal 
line). Cultures 1 to 4 were stained with a rabbit antibody (Santa Cruz), while culture 5 was stained 
with a mouse antibody (Abcam), n = 3-6 measurements per cell isolation, means ± SD. 
 Detection of pericytes in muscle sections 1.4.
1.4.1. Methodology 
In the next step sections from hamster cremaster were analyzed with regard to pericyte 
markers. Pericytes have been described to be found in close vicinity of small vessels and are 
expected to stain positive for the markers that have been found in western blotting and flow 
cytometry. For this purpose cross and longitudinal sections of thigh and cremaster muscle 
were subjected to immunohistochemistry. A staining for lectin was used to identify the 
endothelium of microvessels. 
1.4.2. αSMA positive cells are found in the immediate vicinity of skeletal muscle 
microvessels 
Since hamster pericytes were positive for the expression of αSMA in western blotting and 
immunostainings, αSMA was chosen as a marker protein to analyze the in vivo presence and 
distribution pattern of pericytes in hamster cremaster muscle. Paraffin sections were stained 
with a mouse antibody against αSMA and microvessels visualized by co-staining with 
fluorescently labeled lectin. Vascular smooth muscle cells also stained positive for αSMA in 
tissue sections but could be distinguished by their characteristic shape and the lack of further 
marker expression (KV1.5). 
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Figure IV-6: Staining of αSMA positive cells (green staining and arrows) in 16µm paraffin sections of 
hamster cremaster muscle, vessel staining was performed with lectin (red fluorescence and arrow). 
Red staining within the vessel is likely caused by erythrocyte autofluorescence. Representative 
confocal images were taken with a 63x objective, zoom 1x (left), zoom 3.2x (right); Scale bars: 20 µm 
 
 
Figure IV-7: Staining of NG2 positive cells (green staining and arrows) in 5µm paraffin sections of 
hamster cremaster muscle. Vessels were stained with lectin (red fluorescence and arrows); 
Representative confocal images were taken with a 63x objective, zoom 1x (left), zoom 3.2x (right); 
Scale bars: 20 µm 
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Figure IV-8: Staining of 3G5 positive cells (green fluorescence and arrows) in 5 µm hamster cremaster 
muscle paraffin sections; Confocal images taken with 63x objective, zoom 1x (left), zoom 3.2x (right); 
Scale bars: 20 µm 
1.4.3. Sympathetic nerve cords along microvessels are also stained with 3G5 
Staining of isolated hamster microvessels for 3G5 positive cells also cells yielded a string like 
fluorescence pattern that was most likely not caused by pericytes. Since neurons have also 
been described to be recognized by the 3G5 antibody this pattern is presumably caused by 
sympathetic innervation of the vessel ([178, 179], Figure IV-9). 
 
Figure IV-9: Staining of hamster microvessels against the 3G5 antigen shows a specific linear 
fluorescence on the outside of the vessel most likely resulting from neuronal cells from the 
sympathetic nervous system (green arrows). Confocal images at two independent sites and with 
different magnifications are shown.40x objective, zoom 1x (left), zoom 3.2x (right); Scale bars: 50 µm 
58 Results 
 
2. Pericytes can generate electrical signals using KV1.5 
potassium channels 
Pericytes of capillaries are situated at the interface between the endothelial layer and the 
tissue cells. There they could act as signal generators and mediators for an electrical signal 
that is conducted along the vessel wall (endothelium). An essential prerequisite to generate a 
hyperpolarization is the presence of functional potassium channels [48]. For this reason patch-
clamp experiments were performed to elucidate the presence of potassium channels in 
pericyte membranes. 
 Electrophysiology points towards KV1.5 membrane potassium 2.1.
channels 
2.1.1. About 30 percent of pericyte cultures show voltage dependent channel activity 
More than 200 cells in 60 cultures were subjected to patch clamp analysis. 44 cultures 
(73.3%) exhibited a complete lack of channel activity (whole cell conductance < 0.1 pS/pF), 
independent of culture age and duration of incubation. Input resistance of these cells was high 
and could not be altered by depolarizing voltage application, I/V relationships were 
completely linear. Furthermore application of FFA did not alter the activities. In contrast, 
despite no apparent differences in the isolation protocol, 16 cultures with a total of 48 cells 
showed a voltage-dependent channel activity of variable degree in the depolarizing range. In 
these cultures essentially all cells exhibited the activity. 
Resting membrane potential measurements indicated differences between cells with channel 
activity and cells that did not exhibit channel activity. While in cells without channels resting 
potential was in the range between -20 to +10 mV, in cells with channels it showed values in 
the -20 to -60 mV range. Membrane capacitance was determined in whole cell mode to be 
between 30 and 600 pF. Voltage perturbation towards depolarization resulted in a rapid 
activation of the channels within 25 ms for up to 200 ms (Figure IV-10). 
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Figure IV-10: Cells from pericyte cultures show a voltage dependent channel activity in whole cells 
patch 
2.1.2. The voltage dependent activity is likely mediated by voltage gated potassium 
channels 
In order to clarify the ion specificity of these channels the extracellular potassium 
concentration in the bath was increased 10-fold from 3 mM to 30 mM. This intervention 
induced only a small shift in the current/voltage (I/V) relationship (data not shown). In order 
to analyze the effect more sensitively the antiphlogistic drug flufenamic acid (FFA) was used 
in addition. In pericyte cultures FFA strongly increased the voltage-dependent current in the 
presence of 3 mM potassium (open vs. filled circles in Figure IV-11). Furthermore under 
these conditions an increase of the extracellular potassium concentration to 30 mM led to a 
change in the reversal potential of the voltage / current (I/V) relationship by 51 mV, which is 
close to a Nernstian response (filled squares vs. open circles in Figure IV-11). The experiment 
was conducted three times in cultures that exhibited a particularly high channel activity 
yielding similar results. 
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Figure IV-11: Electrophysiologic properties of potassium channel activity under treatment with FFA 
and elevated K+ concentrations from a typical experiment 
2.1.3. TEA and 4-AP modulate membrane channel activity 
To investigate the channel properties in more detail additional channel modulating substances 
were used. In the current study two different blockers of potassium channels were chosen to 
characterize the nature of the involved channels in more detail: tetraethylammonium (TEA) 
and 4-aminopyridine (4-AP). TEA at 10 mM was ineffective. In contrast application of 4-AP 
reduced the slope of the I/V in the depolarizing range dose dependently and reversibly. At 10 
mM 4-AP, the I/V relationship was virtually linear over the entire analyzed range. The resting 
membrane potential decreased to about -20 mV. In pericytes from hamster skeletal muscle the 
half-maximal effective concentration for channel inhibition by 4-AP was 1.25 mM (Figure 
IV-12B) determined at 0 mV. 
A 
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B  
Figure IV-12: (A) Dose-dependent inhibition of the patch-current by 4-AP in pericytes, (B) dose-
response relationship of the experiment shown in A for the slope at a potential of 0 mV 
2.1.4. Analysis of further channel involvement 
Control experiments were conducted to exclude any influence of calcium or other types of 
potassium channels on the results shown above. For this purpose channel blockers and 
specific stimuli were used. Glibenclamide (n=5, data not shown), an inhibitor of ATP-
sensitive potassium channels showed no effect, either spontaneously or in the presence of 
FFA. Similarly exposure of the cultures to the muscle metabolites lactate (n=4, 10 mM), ATP 
(n=3, 1 mM) and adenosine (n=2, 500 µM) had no effect within 15 minutes (data not shown).  
Chloride channels are sensitive to inhibition with flufenamic acid and should therefore have 
been blocked in most of the experimental setups shown mentioned before. To increase the 
reliability of these findings additional experiments were performed in which the bath chloride 
was replaced with gluconate. As shown in Figure IV-13 there was no effect on baseline 
conductance or I/V relationship excluding Cl
-
 channel effects in the cultured pericytes. 
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Figure IV-13: The replacement of chloride with gluconate in the culture medium induced no change 
in the I/V relationship 
 Western Blot shows the presence of KV1.5 channels 2.2.
Since the electrophysiological properties and inhibition characteristics clearly pointed towards 
KV1.5 channels in the membrane the expression of these channels was analyzed in western 
blotting. In these experiments HUVEC and HeLa cells served as positive controls. Although 
the polyclonal antibody used in this experiment was only tested by the manufacturer for 
specific reactivity in rat and mouse cells, a clear band at the right height could also be 
detected in hamster skeletal muscle pericytes as shown in Figure IV-14. 
 
Figure IV-14: Western blotting with a polyclonal rabbit antibody (Sigma) demonstrates the expression 
of the KV1.5 channel protein in cultured pericytes. HeLa cells and HUVEC served as positive controls. 
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3. KV1.5 positive cells are present in tissue sections 
To confirm the presence of KV1.5 expressing pericytes in vivo, tissue sections were stained 
for the expression of KV1.5 in NG2 positive cells. As shown by confocal microscopy in 
Figure IV-15, single cells in close vicinity to small vessels stained double positive with both 
markers. The expression of KV1.5 therefore does not seem to be restricted to cells under cell 
culture conditions, but also occurs in vivo. 
 
Figure IV-15: Immuno-staining of a microvessel in 5 µm hamster cremaster paraffin sections with 
antibodies against NG2 (red fluorescence and arrows) and KV1.5 (green fluorescence and arrows); 
The two antigens co-localise in the same cell in the vessel wall. 63x objective, zoom 1x (left) and 4.1x 
(right); Scale bars: 20 µm 
Interestingly the distribution of KV1.5 positive cells was not uniform in the microcirculatory 
system. Instead cells expressing this marker were found predominantly at sites of vascular 
branching as shown in Figure IV-16. 
 
Figure IV-16: Staining of a vascular branching in hamster cremaster muscle for reactivity with an 
antibody against KV1.5 (green fluorescence and arrows); 63x, zoom 1 (left) and 3.2 (right). Scale bars: 
20 µm  
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4. Pericytes communicate with adjacent endothelial cells 
via gap junctions 
 Pericytes express the gap junction protein Cx43 4.1.
In order to find out whether the cultured pericytes are able to form functional gap junctions 
the expression of connexin (Cx) proteins as a prerequisite for gap junctional communication 
was investigated. Cell lysates of primary pericyte cultures were tested for the expression of 
the vascular connexins Cx37, Cx40 and Cx43 at the protein level by western blotting. Stably 
transfected HeLa cells served as positive controls and connexin deficient HeLa wildtype cells 
(HeLa wt) as negative controls in these experiments. While no expression of either Cx37 or 
Cx40 was detectable in pericytes (PC), they showed expression of Cx43 (Figure IV-17). 
 
Figure IV-17: Western Blot analysis for the expression of Cx37, Cx40 and Cx43 in pericytes. Stably 
transfected HeLa cells expressing Cx37, Cx40 or Cx43 served as positive controls and HeLa wt cells as 
negative controls. Pericytes express specifically Cx43, but not Cx37 and Cx40. 
Immunofluorescence stainings of Cx43 in primary pericyte cultures with a connexin 43 
selective antibody showed the typical dotted staining pattern for Cx43 in the membrane 
mainly at contact sites with adjacent cells (Figure IV-18, [180]). 
 
Figure IV-18: Immunofluorescence staining for Cx43 expression in pericyte cultures. Cx43 is mainly 
localised at the membrane especially at cell-cell contacts (arrows). 
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 Pericytes form functional gap junctions with endothelial cells 4.2.
To analyze for functional gap junction coupling between pericytes and endothelial cells, co-
culture experiments with pericytes and HUVEC were performed. For this purpose n=40 
pericytes in five co-cultures were observed over a time of 5-10 minutes. In Figure IV-19 on 
the left image, a pericyte injected with the gap junction permeable fluorescent dye Alexa 
Fluor488 can be seen surrounded by endothelial cells at the beginning of the experiment. Five 
minutes later the spread of the fluorescent dye to those neighboring cells can be observed as 
an increase in fluorescence in HUVEC. 
 
Figure IV-19: The small molecular fluorescent dye Alexa Fluor 488 spreads from an injected pericyte 
(PC) to neighboring HUVEC (Hu) through gap junctions within 6 minutes after injection. Color 
intensities indicate strength of the fluorescent signal. While 1 minute after injection only a weak 
signal can be seen in HUVEC, after 5 minutes the signal strength strongly increases. Representative 
images from n=40 PC in 5 cultures shown. 
 A hyperpolarization can be conducted from pericytes to endothelial 4.3.
cells 
Functional gap junctions could mediate a conducted dilation from pericytes to endothelial 
cells. To address this question the microscopy setup was modified to use membrane potential 
measurements as a functional read-out. Remarkably flufenamic acid (FFA) at a concentration 
of 300 µM was able to induce a hyperpolarization only in part of the pericytes, but had no 
such effect in HUVEC. Therefore HUVEC were pre-labeled with the red fluorescent dye 
PKH-26 to allow for easy identification and put in co-culture with pericytes. Under these 
conditions HUVEC directly in the vicinity of PC reacting to FFA (n=7) also showed a 
hyperpolarization of their membrane potential, but more remote cells did not (n=4 PC cultures 
and n=4 HUVEC donors). Of note long incubation times (more than 30 minutes) abolished 
the effect, but also inhibited the gap junctional transfer of Alexa 488. This suggests a slowly 
developing, DiBAC4(3) mediated inhibition of gap junctional communication. 
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Figure IV-20: A flufenamic acid induced hyperpolarisation can spread to HUVEC that are coupled via 
gap junction channels but not to remote cells. HUVEC that had been directly coupled to pericytes 
showed a similar decrease in their delta mean grey value (red squares v s. blue diamonds) whereas 
remote HUVEC did not exhibit this effect (green triangles). The distributions of the three groups were 
significantly different (p<0.001. Kruskal-Wallis test for independent samples). 
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5. Gap junctions as a potential communication pathway 
between pericytes and endothelial cells 
In order to investigate further possibilities of signal transduction at the gap junctional 
interface, experiments were conducted in which HeLa cells transfected with miRNA were co-
cultured with miRNA-detector HeLa cells in the presence and absence of connexin 
expression, which is a prerequisite for gap junction formation. For this purpose a literature 
search on miRNA was performed in PubMed to select a well characterized miRNA with an 
experimentally validated target sequence that is not expressed in HeLa cells. The neuronal 
miRNA miR124 satisfied these criteria adequately [142] and was therefore selected for the 
subsequent experiments. Furthermore it is known to be an inducer of neuronal differentiation 
in N2A cells and to act by de-repressing a neuron specific gene set on the transcriptional level 
[181]. HeLa cells were used because of their absence of connexin expression in the wildtype. 
 miR124 induces a neuron-like phenotype in HeLa cells 5.1.
Direct transfection of HeLa cells with miR124 led 2-3 days post transfection to distinct 
morphological changes in the HeLa phenotype. The cells acquired a more elongated shape 
with large protrusions that often extended towards other cells. These morphological changes 
suggest cell differentiation and the induction of a neuron-like phenotype in these cells. 
 
Figure IV-21: A neuron-like phenotype is observable in HeLa cells 2-3 days post transfection with 
100 nM miR124; representative images of three independent experiments shown on the same scale 
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 miR124 leads to a cell cycle arrest in HeLa cells 5.2.
Flow cytometric analysis of cell cycle phases of mir124 transfected HeLa cells 2 days post 
transfection indicated a cell cycle arrest in the G0/G1 phase. While in untransfected and 
negative control transfected cells 64% and 66% were in the G0/G1 phase at the time of 
analysis, miR124 transfected cultures contained 82% cells in G0/G1 phase (Figure IV-22). In 
these experiments care was taken for the cultures not to reach confluence until they were 
harvested. 
Due to the limited sample size (n=4 experiments) it was not possible to check adequately for 
normal distribution of the data. Therefore a conservative approach was chosen and a non-
parametric statistical test performed. The paired Wilcoxon Signed Ranks test on the 
percentage of cells currently in G0/G1 phase between the groups was not significant for all 
comparisons, probably also due to the small size of the groups (p=0.465 between untreated 
and neg. control transfected cells and p=0.063 for the comparison of miR124 transfected cells 
with either of the two other groups). 
  
Figure IV-22: Distribution of cell cycle phases in untreated, neg.control transfected and miR124 
transfected HeLa cells. Transfection with synthetic miR-124a induced a strong increase of the 
percentage of cells in the G0/G1 phase, indicating a cell cycle arrest in G0/G1 phase (means ±SD, 
n=4). 
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 Dye coupling through gap junctions is preserved after transfection 5.3.
with miR124 
Since it could not be excluded that the transfection with miR124 had an influence on gap 
junctional coupling a parachute dye transfer assay was performed with the miRNA transfected 
cells. For this purpose HeLa wt, as well as HeLa43 cells were transfected with miRNA and 
two days later dye transfer was quantified using flow cytometry. As shown in Figure IV-23 no 
significant inhibition or induction of gap junctional communication could be observed. 
 
Figure IV-23: Graphical representation of dye coupling over time in a parachute assay (n=3, means 
+/- SEM); Statistically significant differences exist within the time course of the fluorescence intensity 
in HeLa43 cells (p<0.001), but not for the time course in HeLa wt cells (p=0.757). Transfection with 
miR124 is no significant factor for either HeLa43 cells (p=0.204) or HeLa wt cells (p=0.838). HeLa43 
and HeLa wt are significantly different in the progression of the fluorescence intensity over time 
(p<0.001). (univariate general linear model analysis) 
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 miR124 decreases the luciferase activity in directly transfected 5.4.
HeLa43 
The efficiency of miR124 induced reporter gene silencing in the luciferase reporter system 
was quantified in HeLa43 cells. To this end HeLa43 were co-transfected with the reporter 
plasmids and miR124 or miRNA control. On the next day luminescence was quantified. In 
these experiments, transfection with miR124 resulted in a 85% decrease in reporter gene 
expression levels compared to control transfected cells (Figure IV-24) after two days. This 
indicates that the system sensitively and specifically quantifies intracellular miR124 
concentrations. 
 
 
Figure IV-24: Luciferase activity measured in HeLa43 cells co-transfected with miR124 and the 
luciferase reporter plasmid showing a strong downregulation compared to cells transfected with a 
non-silencing negative control miRNA and the luciferase reporter (n=3, means ±SEM). 
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 Analysis of gap junctional miRNA transfer in co-cultures of Cx43 5.5.
transfected HeLa cells 
5.5.1. Co-cultures with transfer of miR124 
Since the transfection of miRNA and reporter plasmid in one cell population resulted in a 
strong response in the next step we attempted to measure a potential miRNA transfer through 
gap junction channels in Cx43 expressing HeLa cells. For this purpose reporter gene 
transfected Hela43 cells were co-cultured with “donor” HeLa cells transfected with miR124. 
These “donor” cells were either connexin deficient (HeLa wt, Figure IV-25 A) or expressed 
connexin 43 (Figure IV-25 B). HeLa cells that were solely transfected with the luciferase 
reporter plasmids served as a control (Figure IV-25 A). 
While co-culture with HeLa wt cells did not have a significant effect on luciferase expression 
levels in the acceptor cells, co-culture with miR124 transfected HeLa 43 significantly 
diminished luciferase expression and therefore light emission (p=0.043, Wilcoxon matched-
pair signed-rank, Figure IV-25B).  
 
Figure IV-25: Co-culture with miR124 transfected cells diminished luciferase activity generated by 
detector cells only, if donor, as well as detector cells express functional Cx43 and the cells therefore 
can couple via gap junctions (n=5, means +/- SEM normalized to wt-controls, * denotes p<0.05, 
Wilcoxon match-pair signed-rank). RLU represents relative luminescence units showing Renilla 
luciferase measurements normalized to Firefly luciferase measurements from the same sample. 
After these experiments showed promising results for the potential intercellular transfer of 
miRNA between cells, further experiments were designed to characterize the observed effect 
in more detail. These experiments were conducted without the sorting step that had been used 
before and also included a control detection plasmid that was mutated in the miRNA 
recognition site. 
In this set of experiments directly miR124 transfected detector cells showed a strong decrease 
in normalized luminescence activity confirming correct operation of the detection system (bar 
6 in Figure IV-26A). This miR124 induced decrease was completely abolished in the mutated 
detector system (bar 6 in Figure IV-26B). 
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In contrast to previous results under co-culture conditions no attenuation of the luciferase 
signal could be observed in detector cells that had been in co-culture with miR124 transfected 
donor cells for two days (Figure IV-26A). Remarkably, despite constant cell number and 
culture circumstances, detector cells with the wildtype detection construct that were not in co-
culture with miRNA transfected donor cells showed a much higher RLU value compared to 
the co-cultured HeLa detector cells (bar 5 in comparison to bars 1 through 4 in Figure 
IV-26A). Experiments with detector cells that had been transfected with the mutated detection 
plasmid also did not show any attenuation of the luciferase signal following co-culture with 
miR124 transfected donor cells (bars 1 through 5 in Figure IV-26B). In these cells the above 
described increase in detector cells without co-culture was not detectable (bar 5 in Figure 
IV-26B). Since only three experiments were performed no statistical evaluation is shown. 
 
A 
  
 
B 
 
Figure IV-26: Relative luminescence values for 2d co-cultured HeLa cells in the modified experimental 
setup without cell sorting (n=3, means +/- SEM). (A) shows experiments with the wildtype miR124 
target luciferase construct, (B) shows results for the 3-5 mutated miR124 target luciferase plasmid. 
Lower mean RLU values in the experiments with the mutated plasmid are mainly caused by 
noticeably lower raw Renilla luciferase activity values. The reason for these altered raw expression 
levels is yet unknown and might lie in the plasmid as well as in the transfection procedure. RLU 
represents relative luminescence units showing Renilla luciferase measurements normalized to Firefly 
luciferase measurements from the same sample. 
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5.5.2. Co-culture experiments using miR15b 
In view of these divergent results the system was further adapted to use the second miRNA 
miR15b and its respective detection system (“miR15b wild-type plasmid”). In these 
experiments as well a mutated miR15b detection plasmid was used that had base exchanges in 
the positions 3 to 5 of the seed recognition sequence of the miRNA (“mutated plasmid”, for 
details see the “Materials and methods” section). To enable statistical analysis experiments 
were repeated seven times. 
Figure IV-27A shows the results from the wildtype plasmid, Figure IV-27B from the mutated 
plasmid. While direct transfection with miR15b resulted in a significant downregulation of 
luciferase activity in the wildtype transfected cells (p=0.018, Figure IV-27A, bar 6), luciferase 
activity in cells transfected with the mutated plasmid remained unchanged (p=0.128, Figure 
B, bar 6), confirming the correct operation of the detection plasmids. 
Co-culture of miR15b donor cells with detector cells containing the miR15b sensitive plasmid 
showed no significant attenuation of luciferase activity in connexin 43 expressing cells 
compared to donor cells transfected with a negative control plasmid (p=0.051, bars 3 and 4 in 
Figure IV-27A). Moreover, there were no statistically significant differences between either 
co-culture experiment and the not co-cultured control detector cells (bars 1 through 4 
compared individually to bar 5 in Figure IV-27A, for p-values see Table IV-1). 
Using the mutated detection system luciferase measurements in co-culture experiments with 
connexin deficient donor cells were generally higher than in co-cultures with Cx43 expressing 
HeLa cells (bars 1 and 2 compared to bars 3 and 4 in Figure IV-27B, not statistically 
evaluated) and compared to not co-cultured detector cells (p=0.028 and p=0.018 for the 
comparisons of bars 1-5 and bars 2-5 in Figure IV-27B). Also in this system there was no 
statistically significant difference between co-cultures with miR15b and negative control 
miRNA transfected Cx43 donor cells (p=1.000, bars 3 and 4 in Figure IV-27B). 
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Figure IV-27: HeLa43 co-culture experiments with miR15b for the intercellular transfer of miRNA. (A) 
experiments with the wildtype miR15b detection plasmid (n=7-13, means ± SEM) and (B) with the 
plasmid with the mutated miR15b recognition sequence (n=7, means ± SEM). p-values smaller than 
0.05 from the analyzed comparisons given in the next table are marked with bars. RLU represents 
relative luminescence units showing Renilla luciferase measurements normalized to Firefly luciferase 
measurements from the same sample. 
Groups compared p-value wt-plasmid p-value mutated plasmid 
1 – 2 0.173 0.499 
3 – 4 0.051 1.000 
5 – 6 0.018 0.128 
1 – 5 0.221 0.028 
2 – 5 0.507 0.018 
3 – 5 0.515 1.000 
4 – 5 0.260 0.866 
Table IV-1: Statistical comparison of the subgroups from the miR15b transfer experiments. The 
numbers in the first column refer to the respective bars in the previous figure. p-values were 
calculated with a paired samples Wilcoxon signed ranks test and the results are shown separately for 
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the wildtype plasmid (left column) and the mutated plasmid (right column). Significant values are 
marked in red. 
 V Discussion 
1. Establishment and validation of an isolation protocol for 
hamster skeletal muscle pericytes 
Although pericytes have been first described nearly 140 years ago they still remain not fully 
understood and especially studies on pericytes in peripheral organs such as skeletal muscle are 
scarce. Most studies on pericytes were performed in neuronal tissue, especially in pericytes 
from bovine retina [182, 183] and brain [184], whereas there are only few or single reports 
from lung [185], skin [186, 187], heart [188] and pancreas [189]. 
It is therefore difficult to say, whether “peripheral” pericytes have the same properties as 
those of neuronal organs. Moreover there are obvious differences within one organ with 
respect to the type of vessel they are associated with, i.e. veins and arteries [190-192]. 
Furthermore changes can occur: for example the expression of the NG2 epitope becomes up-
regulated along venules during microvascular remodeling [193] and pericytes contribute to 
the vascular adaption processes during hyperoxia in the retina [194]. This suggests that 
pericytes represent a very plastic cell type. Indeed, pericytes have been shown to have the 
inherent potential to differentiate into other terminally differentiated cell types depending on 
the stimulus. In this respect they might be similar to embryonic mesoangioblasts in their 
ability to differentiate to SMC [67, 69, 195, 196], skeletal muscle cells [67] osteoblasts and 
adipocytes [197], chondrocytes, phagocytes [198] and fibroblasts [69, 196, 199]. 
The identification of pericytes and their further differentiation relies heavily on the detection 
of certain surface markers. For example, a recent publication analyzed pericytes from skeletal 
muscle biopsies for their myogenic potential studying the markers alkaline phosphatase, NG2, 
PDGFR-β and αSMA [67]. In agreement with our study, the authors found that the expression 
of specific markers was not generally found in all pericytes but only in subsets of the whole 
population. The markers also are not restricted to pericytes. While alkaline phosphatase is also 
expressed in endothelial cells of heart and skeletal muscle, NG2 represents a marker for 
pericytes/smooth muscle cells in the developing vasculature [200]. Further, not purely 
pericyte specific markers have been proposed recently, such as the ATP-sensitive potassium-
channel Kir6.1 (also known as Kcnj8) and sulfonylurea receptor 2, (SUR2, also known as 
Abcc9), as well as delta homologue 1 (DLK1). Interestingly Kir6.1 could only be detected in 
brain pericytes of mouse embryos, but was undetectable in pericytes in skin and heart [63]. 
Using a negative approach, previous studies have attempted to identify pericytes by the 
absence of typical characteristics of neighboring cell types such as the endothelial cell marker 
CD31, diI-acetylated low-density lipoprotein uptake, cytokeratin 5, 6, and 18, and the S100 
protein [187]. 
All current data in the literature indicate that, due to this high structural and functional 
heterogeneity [78], there is no single and exclusive pericyte marker available that will work 
equally well in all tissues. Therefore in the current study a stepwise isolation and 
characterization protocol was used that involved immunomagnetic isolation of skeletal muscle 
pericytes via the 3G5 epitope and further cultivation of the cells in a selective medium to 
enrich pericytes and reduce potential contamination with other cell types. 
The surface antigen 3G5 represents a well-established marker of vascular pericytes [159, 186, 
201], that has previously also been identified in the foci of calcification in complicated 
atherosclerotic plaques [202], suggesting a role in vascular pathology. Furthermore a small 
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population of bone-marrow derived mesenchymal stem cells is also known to stain positively 
for 3G5 [203]. The 3G5 ganglioside antigen has also been well characterized in microvascular 
pericytes [158] although cellular expression levels of 3G5 have been reported to vary in cell 
culture [158, 204]. One of the reasons for this observation might not be heterogeneity of the 
population itself but rather varying expression levels during the cell cycle [205]. This 
preselection on 3G5 has the inherent risk that subsets of pericytes may have been not analyzed 
or that bone marrow derived cells may have been included. 
A further step to select pericytes was the use of a pericyte specific medium. This medium was 
created to inhibit the growth of potentially contaminating endothelial and smooth muscle cells 
and did not contain the growth factors needed by these cell types. In the same manner the 
plastic culture dishes were not coated with collagen or fibronectin since pericytes have been 
described before not to be dependent on exogenous substrates for adhesion and be able to 
synthesize their own matrix [206-208]. 
The discriminating effect of the medium could be clearly shown in HUVEC and PAEC 
cultured in pericyte medium (Figure IV-2). While 3G5 purified pericyte cultures kept 
growing, endothelial cells gradually died over time leaving a few cells that resembled 
pericytes. Of note an enrichment of cell types occurred in long term passaged PAEC cultures 
that expressed pericyte markers and exhibited a cell morphology resembling pericytes. The 
reason for this phenomenon might be that single6 contaminating pericytes had overgrown the 
PAEC over time (see also: [159]). 
Despite advances in the molecular characterization of pericytes, because of their strong 
heterogeneity, morphological criteria and growth patterns are still considered a relevant part 
of the definition of a pericyte. One of the features commonly ascribed to pericytes is nodule 
formation in confluent cultures [68, 209]. These pellets are embedded into a self-synthesized 
extracellular matrix with prominent amounts of sulfated proteoglycans and type II collagen 
[197]. Furthermore they have been described to be “large and well spread with irregular edges 
and prominent stress fibers.” [187]. 
As shown in Figure IV-1 the morphology of the isolated cells on day 15 was in accordance 
with these criteria. Furthermore the cells in the culture dish showed distinct variations in 
phenotype and were varying in size and in the length of their protrusions. This could be an 
indication of the cells originating from different vascular backgrounds, e.g. venous and 
arterial, although under prolonged culture conditions the in vivo marker pattern is impossible 
to trace [190, 210]. For example no expression of NG2 has been reported in vivo in venous 
pericytes [190], but it became expressed during induction of vascular remodeling [193]. For 
these reasons the heterogeneity allows no inferences on the primary vascular region from 
which the pericytes were obtained. 
On the protein level the cultured cells were positive in western blotting for alpha-smooth 
muscle actin, NG2 and PDGFR-β. If there was a potential contamination with endothelial 
cells it was low enough not to give a signal for vWF in the blots. 
Considering that there is a wide range of pericytic phenotypes and markers, global analytical 
methods such as western blotting or rtPCR can only yield information on their average 
distribution in a cell population. Subsets of cells or typical combinations of markers can only 
be detected by additional methods such as immunostaining and imaging of cells. For this 
reason also immunostainings were performed to analyze marker expression on the single cell 
level. 
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Four different marker proteins were chosen that have been described in pericytes before. α-
smooth muscle actin (αSMA) represents as a marker protein that stains positively in smooth 
muscle cells from the wall of blood vessels, the gut wall and the myometrium. It has been 
described to occur also in microfilamentous bundles in pericytes [211]. Receptors for platelet 
derived growth-factor β (PDGFR-β) have been described to transduce proliferation and 
migration signals in pericytes which are needed in wound healing and angiogenesis but can 
also be found in tumor vasculature [115, 212-216]. They seem to fulfill a vital function since 
mice lacking the respective ligand PDGF-B suffer from pericyte loss and develop 
microaneurysms [217]. NG2 is a proteoglycan that is expressed in the walls of neovascular 
structures. According to Ozerdem et al. [74] “NG2 is expressed in the embryonic heart by 
cardiomyocytes, in developing macrovasculature by smooth muscle cells, and in nascent 
microvessels by vascular pericytes” and can therefore be regarded as a valid pericyte marker. 
As a control marker to identify any potential contamination with endothelial cells, the 
endothelial glycoprotein von Willebrand Factor (vWF) was used. 
In the immunostainings a majority of the cells stained positive for at least one of the markers 
NG2, PDGFR-β and αSMA (Figure IV-4) while they were negative for the endothelial marker 
vWF. A small proportion of the cells did not stain for any of the markers used here. These 
cells might either represent pericytes that are de-differentiating or trans-differentiating into 
another cell type or the marker expression could be cell-cycle dependent as has been 
hypothesized before [205]. Of course it cannot be completely excluded that those cells are 
from a different origin and only resemble pericytes in some but not all respects, such as 
myofibroblasts [186, 218]. Still those cells have been sorted for the 3G5 antigen and they 
were able to grow in selective pericyte medium on untreated plastic dishes [67]. Also not all 
markers were always present in the same cell indicating heterogeneity among the isolated 
skeletal muscle pericytes. One of the reasons for this observation might lie in the isolation 
method. It did not favor the isolation of pericytes from one specific localization in the 
vascular bed, therefore pericytes that in vivo fulfill different functions and are adapted to 
different metabolic and environmental needs may have been co-purified and cultured. 
However there is no evidence for this pattern to be a cell culture artifact, since all the markers 
that were found in cells during cell culture were also found in tissue sections. Furthermore in 
the in vivo immunohistochemistry studies there were distinct differences in the expression 
pattern of the markers depending on the localization of the cell with respect to the vascular 
region. This was especially the case with the potassium channel KV1.5 being expressed 
predominantly by cells localized at sites of vascular branching. Furthermore the selection of 
investigated markers represents only a small fraction of the cellular proteins having been 
described as relatively characteristic for pericytes. Therefore more differences are very likely 
to exist. 
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2. Pericytes as signal generator and mediator cells 
Skeletal muscle pericytes are located at the crossroads between the effector cells controlling 
vascular tone (smooth muscle cells), the electrical signal conductors (endothelial cells) and 
the energy consumers (skeletal muscle cells). They could therefore be involved in generating 
and transducing signals from the tissue to control conducted dilation as mentioned in the 
introduction. Acting as activity-sensors they may well relay signals derived from working 
skeletal muscle into an endothelial hyperpolarization that is needed for upstream signal 
propagation needed to coordinate local and upstream vessel dilations. Due to their long 
processes they are able cover a large area, thereby locally integrating signals from cells 
located both up- and down-stream of the pericytes. 
Even under inhibition of NO- and prostacyclin-synthesis some endothelium dependent, 
agonist-induced vasodilatations remain preserved to a variable extent [219-223]. Therefore, 
an endothelium-derived, vasodilating factor apparently plays an important role in the 
regulation of vascular tone. Since this mechanism involves endothelial cells and is dependent 
on hyperpolarization it has been termed an endothelium derived hyperpolarizing factor 
(EDHF) dependent dilation. Although it was first described by Bolton in 1984 underlying the 
action of carbachol on smooth muscle and endothelial cells in guinea pig mesenteric arteries 
[224], until today no unique factor responsible for all known EDHF-dependent dilations could 
be identified. The current concept therefore is more of an endothelium dependent dilation that 
involves smooth muscle cell hyperpolarization than a single factor. 
Two non-exclusive concepts are therefore considered to be involved: On the one hand EDHF 
as a collective term for several soluble factors that diffuse from endothelial cells to smooth 
muscle cells and induce a local hyperpolarization, and on the other hand EDHF representing 
not a factor but direct electrical coupling between endothelial and smooth muscle cells via gap 
junctions. The factors that have been shown to induce EDHF dependent dilations are 
summarized in Table V-1. Interestingly, the primary mediators of EDHF effects seem to be 
heterogeneous between different sections of the vascular bed, between different organs and 
even between male and female subjects with estrogen representing one factor in the latter 
[225-228]. It has therefore been even proposed to dismiss the term EDHF completely and 
refer to the individual mechanisms in a specific vascular bed directly [229]. Furthermore, 
perturbations of the EDHF system are speculated to be involved in cardiovascular disease and 
dysregulation of blood [230, 231]. 
Molecule Source Target 
Chemical EDHF activity 
PGI2 / Prostacyclin COX 1 and 2 Prostacyclin receptor 
EETs EDHF synthase/cytochrome P450 
epoxygenase 
SKCa and IKCa 
H2O2 Catalase SKCa and IKCa 
K
+
  SKCa and IKCa 
Electrical EDHF propagation 
Gap junctions  TRPV4 and SKCa 
Table V-1: Some of the suggested components in the EDHF mediated response (modified from [232]) 
The generation of a membrane hyperpolarization in endothelial cells is generally regarded as 
the initial step in an EDHF mediated response. The signal elicited e.g. by binding of 
muscarinic receptor agonists, such as Ach, methacoline and muscarine to specific receptors on 
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endothelial cells induces an increase in the intracellular calcium concentration via second 
messengers such as IP3. This in turn activates calcium dependent potassium channels (KCa) 
[233-235], that mediate an efflux of K
+
 ions out of the cell, consequently hyperpolarizing the 
membrane. This effect seems to be mainly mediated by intermediate (IKCa, KCa3.1) and small 
conductance (SKCa, KCa2.3) potassium channels [236-240]. 
 
Figure V-1: Schematic representation of the classical model for conducted dilation. Acetylcholine 
(ACh) binds to muscarinic receptors on the surface of the endothelial cell (EC) leading to a release of 
calcium from intracellular stores mediated by the second messenger IP3. This rise in intracellular Ca
++ 
in turn activates IKCa and SKCa potassium channels leading to a hyperpolarization depicted by the 
symbol Θ across the EC membrane. Since smooth muscle cells (SMC) in the underlying Tunica media 
are coupled to adjacent EC via gap junctions, the electrical signal spreads locally and the 
hyperpolarization of the SMC results in a hyperpolarization of local SMC. In the SMC membrane 
hyperpolarization decreases the opening probability of voltage gated Ca++ channels which causes 
SMC relaxation and consequently a vasodilation. Additionally the increase in intracellular calcium 
also induces the activation of the enzymes ‘endothelial NO synthase’ (eNOS) and cyclooxigenase 
(COX) in EC (in the picture only shown in the cell on the right). Their enzymatic products nitric oxide 
(NO) and prostaglandins (PG) diffuse to adjacent SMC (NO into the cell, PG to membrane receptors) 
and by this also contribute to the vasodilation. EC are not only coupled to SMC but also to other EC in 
the Tunica intima. Therefore the ACh signal can also be passed on to other EC upstream via two 
distinct mechanisms through gap junctions. (1) chemically through the diffusion of the intracellular 
calcium wave (a process that is slower and limited in range) and (2) as an electric signal by 
conduction of the membrane depolarization (representing an EDHF conducted mechanism). In the 
coupled EC the mechanisms described above result in a remote vasodilation (Image based on: [241]) 
For skeletal muscle pericytes to contribute to this regulatory system they need to fulfill a 
number of prerequisites. First they need to have adequate receptors to sense the metabolic 
state of the surrounding microenvironment. This has been shown in pericytes from neuronal 
tissues for a wide range of receptors, e.g. purinergic receptors [242] and ATP sensitive 
membrane channels [96], as well as demonstrating that pericytes are pH sensitive [92]. 
Although most of these studies were performed in brain pericytes, it seemed very likely to 
find a similar pattern of receptors also in skeletal muscle pericytes. Interestingly, in this study 
no effect could be induced by treating the cells with lactate, ATP and adenosine while 
measuring transmembrane voltage and current in patch-clamp. Therefore these stimuli are 
unlikely to lead to a membrane hyperpolarization in skeletal muscle pericytes. Further 
possibilities such as decreases in pH value, hypoxia, inorganic phosphate and carbon dioxide 
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have not yet been analyzed. Additionally a combination of the aforementioned stimuli might 
lower the concentration threshold for each individual stimulus to induce an effect. 
In the next step any activation event has to result in the generation of a hyperpolarizing signal 
at the pericyte membrane that can, as a third step, be transferred through gap junction 
channels to coupled endothelial cells. Therefore the electrical signal generation potential as 
well as the gap junctional coupling of skeletal muscle pericytes was analyzed. To this end 
electrophysiological studies were performed to investigate the expression of ion channels in 
the membrane of skeletal muscle pericytes by whole cell patch clamp. In these tests voltage 
stimulation of the cell membrane resulted in a rapid activation of membrane channels within 
25 ms (Figure IV-10) with no inactivation during voltage perturbation. This represents a clear 
characteristic of voltage gated channels. However, only about a third of the analyzed cell 
cultures exhibited a voltage-dependent channel activity. So it seems that signal generation 
most likely is a function that is not a function of all pericytes. As was laid out before, 
pericytes are not a homogenous population of cells but rather form a phenotypic continuum 
that serves a broad range of functions with electric signal generation being only one of them. 
So the ability to generate this signal might be restricted to a subset of pericytes that, 
depending on variations in culture and isolation conditions was in some cases enriched in cell 
culture and in some cases not present at all. Interestingly, channel activity was more 
pronounced in smaller cells that were not so flat.  
To investigate the ion specificity of the channel, the extracellular potassium concentration in 
the bath was increased 10-fold from 3 mM to 30 mM. Under these conditions a diminished K
+
 
efflux against the increased extracellular K
+
 concentration could be measured, suggesting the 
presence of potassium channels. Treatment with flufenamic acid (FFA) which, among other 
effects described in more detail below, has been shown to activate KV channels led to a 
change in the reversal potential of the voltage / current (I/V) relationship by 51 mV, close to a 
Nernstian response. The magnitude of the effect was therefore close to the change predicted 
for a selectively potassium-permeable channel. 
To examine the channel properties in more detail additional potassium channel modulating 
substances were used. In the current study two different blockers of potassium channels were 
chosen: tetraethylammonium (TEA) and 4-aminopyridine (4-AP). While TEA can block all 
types of potassium channels depending on the concentration used, it is most effective on KCa 
channels [243]. For KV channels a minimum blocking concentration of >5 mM has been 
reported [244-247]. In the pericyte experiments TEA at 10 mM was still ineffective, further 
suggesting KV channel activity, since KCa channels should be blocked at this concentration 
completely. 
4-AP is one of the three isomeric amines of pyridine. Despite its pharmacological uses in the 
treatment of multiple sclerosis [248], it is a relatively selective blocker of the KV1 family of 
voltage activated potassium channels. It has been reported to block at concentrations around 
200 µM to 500 µM [167, 249], without significant effect on the sodium and calcium 
conductances. Application of 4-AP reduced the slope of the I/V in the depolarizing range dose 
dependently and reversibly. At 10 mM 4-AP, the I/V relationship was virtually linear over the 
entire analyzed range. This finding further supports the assumption of KV channel activity in 
the pericyte membrane. 
To exclude the involvement of further ion channel types on the electrophysiological response, 
glibenclamide, an inhibitor of ATP-sensitive potassium channels was used. Under the 
experimental conditions used here it showed no effect, either spontaneously or in the presence 
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of FFA. Any influence of Cl
-
 channel effects in the cultured pericytes was investigated by 
replacing the bath chloride with gluconate. This intervention had no effect either on the 
baseline conductance or the I/V relationship. Furthermore FFA is a known inhibitor of Cl- 
channels and therefore they were most likely blocked in the previous experiments. From these 
data the involvement of Cl
-
 channels in the transmembrane electrical currents is highly 
unlikely. 
FFA was found to stimulate channel activity. FFA is a member of the pharmacological family 
of fenamates. Clinically it is used as a non-steroidal anti-inflammatory drug to alleviate 
inflammation and pain [250] through dose dependent inhibition of TNFα- and LPS-induced 
NF-κB activation and COX-2 expression 9. Additionally it has multiple effects on ion channel 
activities. It has been shown before to inhibit gap junctional communication [251], calcium 
activated chloride channels [169], voltage-gated sodium channels [252], TRPM2 channels 
[253] and non-selectively cation channels [254]. Furthermore it has the potential to activate 
potassium channels [255, 256], as well as TRPC6 [257] and TRPA1 [258] channels. So far we 
were not able to identify a natural, endogenous stimulator of the channels in addition to FFA. 
As already mentioned above, exposure of the cultures to the muscle metabolites lactate, ATP 
and adenosine had no effect on the I/V relationship within 15 minutes observation time.  
In summary the electrophysiological studies pointed towards a potassium channel from the 
KV1 family. Especially the potassium channel KV1.5 is known to be widely expressed in the 
microvascular system, the endothelium and some smooth muscle cells (SMC), although this 
seems to be rather rare [259, 260]. It belongs to the delayed rectifier class and to the Shaker 
potassium channel subfamily. Upon stimulation it is able to generate a membrane 
hyperpolarization by allowing the efflux of intracellular K
+
 ions as could be shown 
experimentally with FFA. 
To test the presence KV1.5 channels cell lysates were subjected to western blotting and 
immunocytochemical stainings with specific antibodies. These studies confirmed KV1.5 on 
the protein, as well as on the cellular level. Furthermore it was also confirmed in stainings of 
tissue sections from hamster cremaster muscle. Although SMCs also stain positively for 
αSMA the observed staining pattern strongly suggests that most of the stained cells in the 
vicinity of skeletal muscle microvessels actually are pericytes. As shown in Figure IV-6 cells 
that exhibit the typical pericyte shape and distribution can be found in the direct vicinity of 
microvessels. These results were confirmed using NG2 (Figure IV-7) and 3G5 (Figure IV-8) 
antibodies to stain further pericytic markers in hamster muscle thin sections. Similar to the 
αSMA stainings, single cells exhibited a positive staining also for these markers indicating the 
presence of pericytes around skeletal-muscle microvessels in vivo and making an in vivo 
function of this channel in skeletal muscle pericytes highly likely. Especially the finding that 
KV1.5 positive pericytes are preferentially located at sites of vascular branching is interesting 
and could represent an important feature in their putative function as signal generators and 
mediators.  
                                                 
9
 Source: Calbiochem datasheet, Cat. No. 343075, revised 14-July-03 
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3. Coupling of skeletal muscle pericytes to endothelial cells 
as part of signal transduction processes 
In the microcirculation but not in large vessels it has already been shown that endothelial cells 
and smooth muscle cells are coupled via gap junctions. As pointed out before, electrical signal 
transduction via gap junctions between endothelium and smooth muscle is part of conducted 
dilation. Gap junctional communication requires very close vicinity of the plasma membranes 
of the two cells involved. Indeed, cell protrusions from endothelial or, more rarely, vascular 
smooth muscle cells can be observed in “holes” of the internal elastic lamina separating the 
respective cell layers. In these myo-endothelial junctions the opposing cells are coupled via 
gap junctions. This phenomenon has been first described in small arteries from dog heart in 
1957 [261]. 
Gap junctional coupling plays a central role in conducted dilation. This could be shown by 
inhibiting myo-endothelial gap junctions with blocking antibodies which abolished the EDHF 
induced vasodilation in rat small mesenteric arteries [262]. Gap junctions therefore are an 
integral part of the current explanation of the EDHF signaling pathway [55, 263, 264]. Myo-
endothelial coupling has furthermore been shown to play an important role in the 
acetylcholine (ACh) induced and Ca
++
 mediated vasodilation that induces a hyperpolarization 
in the smooth muscle cells [47, 265, 266]. 
Here we show that also pericytes and EC can couple via gap junctions. Coupling of pericytes 
with other cell types has been shown before to exert a regulatory function in the 
microvascular environment. The coupling between pericytes and polymorpho-nuclear 
neutrophils (PMN) for example has been attributed to a role in the regulation of vascular 
permeability by the production of sulfidopeptide leukotrienes [267]. Conducted dilation via 
the endothelium on the other hand is a very rapid process, occurring virtually instantly after 
the initial local stimulation, suggesting a mechanism involving electrical coupling via gap 
junctions rather than diffusion of mediators [268]. Therefore, if pericytes are local signal 
generators in the process of conducted dilation, their direct coupling via gap junctions to the 
endothelium would be essential. Gap junctional coupling has been described before between 
pericytes and capillary endothelium in the embryonic rat basal forebrain [269]. Also in the 
retina, communication within the endothelium as well as between endothelial cells and 
pericytes has been described, although this way of communication seems to be associated 
with a higher voltage loss and therefore imply a less efficient transmission [270]. By 
providing a low resistance, low voltage loss pathway for the spreading of a pericyte generated 
hyperpolarization the endothelium might connect pericytes among themselves for the 
coordinated regulation of vascular tone [270]. 
In the current study coupling could be demonstrated for skeletal muscle pericytes to HUVEC 
by the transfer of a fluorescent dye in micro-injection experiments. Furthermore in a 
functional assay, gap junction mediated conduction of a hyperpolarization between signal 
generating pericytes and adjacent endothelial cells could be shown. A further indication on 
the involvement of gap junctions came from a side effect of the membrane potential sensitive 
dye DIBAC4(3). Over prolonged periods of time DIBAC4(3) is able to inhibit gap junctional 
coupling. In the current experiments this effect was also able to inhibit dye transfer as well as 
the spread of an electrical hyperpolarization. Of course signal conduction as well as 
generation might not be a common feature of all pericytes in skeletal muscle but also not in all 
tissues. Pericyte isolates from human foreskin for example did not exhibit gap junctional 
coupling [186]. Nevertheless these experimental results support the viability of the concept, 
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that PC may generate a signal elicited by local environmental factors and directly relay it to 
endothelial cells that spread the message up- and downstream. 
Western blotting revealed that pericyte-endothelial coupling was most likely mediated by 
channels formed by connexin 43, since Cx43 was the only vascular connexin protein that 
could be detected in pericyte lysates. In contrast endothelial cells also express Cx40 and Cx37 
(own data and [271]). 
The potential role of pericyte-endothelial gap-junctional coupling implies that an impairment 
of the coupling may potentially play a role in some vascular diseases. In diabetic retinopathy 
for example elevated levels of glucose lead to the downregulation of Cx43 expression and 
therefore induce an inhibition of gap junctional communication in retinal pericytes. This 
would in turn lead to a disruption of vascular homeostasis [272]. Similar to the vasomotor 
response a pericyte-generated hyperpolarization could also facilitate a calcium influx into 
venous endothelial cells, which induces endothelial retraction and opening of intercellular 
clefts [273], for example during an inflammatory reaction. There also have been reports on a 
gap junction mediated differentiation of porcine aortic smooth muscle cells (PASMC) by co-
cultured porcine aortic endothelial cells (PAEC) that involves activation of TGF-β signaling 
[274]. 
Additionally Cx43 has been reported by Hirschi et al to play a central role in probably 
another, long term endothelial cell - pericyte communication. They reported that a knockout 
of vascular Cx43 or inhibition of gap-junctional communication blocked TGF-β activation 
and endothelial-induced mural cell differentiation in mice [58]. The functional relevance of 
this finding is still discussed controversially in the literature (e.g. Sandow and Siegl [48, 
275]). 
Gap junctions are mainly known for their ability to allow cells the exchange of small 
signaling molecules such as ions, cAMP and IP3 across cell borders. This mechanism has been 
reported before for the transfer of small molecules and nucleotides through myo-endothelial 
junctions [184]. However, small signaling molecules and changes in membrane potential 
represent unspecific signals that get interpreted specifically by the cell-type they are 
transferred to. Transfer of miRNA would in contrast enable cells to directly exchange very 
specific gene-regulatory information. This process could be of use in a number of situations, 
such as angiogenesis and the repair of defects in the vessel wall via endothelial progenitor 
cells. As well it might be important in the adaptive vascular growth as well as angiogenesis in 
skeletal muscle under chronic exercise. Indeed, transfer of small RNA molecules has been 
shown already between cells: it could be shown experimentally in rat kidney cells that the 
gene for DNA polymerase β could be downregulated by the intercellular transfer of a 
synthetic siRNA in gap junction coupled cells [276]. In the current project we therefore tested 
whether in principle an exchange of miRNA could occur between cells through gap junctions 
formed by one of the vascular connexins, Cx43.  
Building upon this background the potential of intercellular transfer of miRNA was analyzed 
in a simplified co-culture model using wild-type and Cx43 expressing HeLa cells and the 
miRNAs miR124 and miR15b. miR124 was chosen because it is of neuronal origin and is not 
endogenously expressed in HeLa cells. miR15b has been described before as a regulator of 
VEGF [175] and has also been proposed as a tumor marker [277]. Interestingly the 
transfection with miR124 was a strong and specific signal to induce a genetic program shift in 
HeLa cells. Two days post transfection they started to develop dendrite-like processes and 
entered a G0/G1 phase cell cycle arrest. 
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Analysis of the miRNA signal was performed following two days of co-culture of donor and 
detector cells. In the detector cells, the luminescence activity of a luciferase reporter plasmid 
was directly controlled by an miRNA recognition site in the 3’ UTR and consequently 
proportional to the amount of a specific miRNA in the cytoplasm. As a result direct 
transfection of acceptor cells with synthetic miRNA led to an 80% to 90% reduction in 
luciferase activity suggesting proper function of the detection system. As well, direct 
transfection with miR15b resulted in a significant downregulation of luciferase activity in the 
cells transfected with the wildtype plasmid, while luciferase activity in cells transfected with 
the mutated plasmid remained unchanged. These data confirmed the correct operation of the 
detection system. 
In initial miR124 experiments, co-culture of acceptor cells with connexin deficient HeLa wt 
cells as donors showed no significant attenuation of the luciferase signal in the acceptor cells. 
In contrast co-culture with stably Cx43 transfected HeLa cells that could act as miRNA 
donors led to a significant reduction of luciferase activity of about 30% following two days of 
co-culture. These data hinted towards the possibility of gap junction mediated intercellular 
transfer of miRNA. 
However, when these experiments were repeated with a modified co-culture system omitting 
the cell-sorting step therefore allowing additional controls and also comprising control 
experiments using a binding-site mutated detection plasmid these results could not be 
reproduced. 
Unlike in the previous experimental series, no differences were found between co-cultures 
with negative control donor cells and with miR124 donor cells. Especially co-cultures with 
coupling deficient HeLa cells and with connexin 43 expressing cells did not show differences. 
Additionally a stronger luciferase signal was observed in the control detector cells that had 
not been kept in co-culture with transfected donor cells, suggesting an unspecific effect of co-
culturing. The underlying reasons for these results are so far unknown. 
In control cells direct transfection with miR15b resulted in a significant downregulation of 
luciferase activity in the cells transfected with the wildtype plasmid, while luciferase activity 
in cells transfected with the mutated plasmid remained unchanged. These data confirmed the 
correct operation of the system. Co-culture of Hela43 detector cells containing the miR15b 
sensitive plasmid with miR15b transfected donor cells showed a very small attenuation of 
luciferase activity that did not reach statistical significance compared to detector cells without 
co-culture or to co-cultures with negative control transfected donor cells (p=0.260 and 
p=0.051, see also Table IV-1). On the other hand a trend towards higher expression levels for 
cells kept in co-culture with HeLa wt donor cells was visible. In acceptor cells transfected 
with the mutated plasmid this decrease in luciferase activity reached statistical significance 
(p=0.028 and p=0.018 against not co-cultured controls) again pointing to the influence of co-
culturing procedures. 
The reasons for these diverging and difficult to interpret results between the two experimental 
setups are unknown and might involve a range of different factors. First of all the stability of 
the synthetic miRNA intracellularly and its protein association is unknown. However these 
factors could be expected to have a strong influence on the availability of a specific miRNA 
for gap junctional transfer. It seems unlikely that miRNA molecules exist freely in the 
cytoplasm, but they are rather bound to proteins from the Argonaute family and other proteins 
[278]. Furthermore miRNA secondary structure, the current cell cycle state and cell density 
effects all could affect the transfer efficiency. 
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It is important to note that the speed of the miRNA exchange is completely unknown. The 
presented data were generated using co-cultures for two days but this might not be the 
optimum conditions. While shorter co-cultures allow less time for the transfer, longer 
experiments seemed impractical for reasons of cell growth. Moreover there were concerns 
about intracellular miRNA stability. Under physiological conditions miRNA half-life seems 
to be a regulatory factor for fine-tuning miRNA effects [279]. Degradation seems to be 
regulated by the miRNA composition outside the seed sequence. The synthetic miRNA 
molecules used in this study were modified by the manufacturer for increased stability and 
long-term effects. The consequences of these disclosed modifications for intercellular transfer 
are hard to judge. On the one hand increased stability could go along with stronger protein 
binding and therefore diminished transfer. On the other hand higher concentrations of miRNA 
for increased periods of time could have beneficial effects in the experiments. Last, the 
exchange efficiency is likely to depend on the type of connexin proteins that are expressed in 
the cell system. By their different pore sizes and charge characteristics they are very likely to 
influence the miRNA transfer efficiency [41, 280-283]. 
While this part of the project was still running other reports were published supporting these 
miRNA related findings. RNA-interference (RNAi) targeted downregulation of GFP was 
shown in human embryonic stem cells stably expressing GFP [284]. Similarly the transfer of 
RNAi was shown with shRNA against GFP in neonatal rat ventricular myocytes [285]. 
Katakowski et al. reported similar findings in 2010 using C. elegans miR-67 in a glioma cell 
model [286]. Only recently in 2011 Lim et al. reported functional transfer from bone marrow 
stroma to breast cancer cells implying a role in the dormancy of bone marrow metastases 
[287]. 
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4. Conclusion and outlook 
The main aim of this project was to establish a reproducible method for the isolation of 
pericytes from hamster skeletal muscle. Using a two-step approach and magnetic bead cell 
sorting a population of cells bearing the morphological characteristics and marker protein 
expression of pericytes was accomplished. The protein pattern in these cells proved to be 
heterogeneous in line with reports from the literature. 
Furthermore, as a proof of principle, signal generation in the isolated cells could be shown to 
be possible via KV1.5 channels. Additionally our pericytes had the ability to couple to 
endothelial cells via gap junctions formed by connexin 43 and transfer a hyperpolarization 
from the pericyte to adjacent endothelial cells. Figure V-2 summarizes the presented findings 
and shows the role that pericytes might play in vascular signaling. While there is still some 
uncertainty as to how pericytes might be stimulated in step 1, pericytes could clearly be 
shown to have the potential to perform steps 2 and 3. 
 
Figure V-2: Summary picture of the hypothesized steps involving pericytes in microvascular signaling 
in the working skeletal muscle. Image based on: [288] 
Although the transfer of miRNA seemed possible in preliminary experiments these results 
could not be confirmed in further testing. Therefore for the transfer of miRNA no conclusive 
results can be reported. Still this subject should be examined further. 
 
 VI Appendix 
1. Summary 
In this thesis a novel method to isolate and cultivate pericytes from hamster skeletal muscle is 
presented. By choosing a two-step approach with magnetic-bead cell sorting for the 3G5 
antigen and culture in a selective growth medium a high percentage of pericytes could be 
reached and their nature could be verified in subsequent characterization steps. 
Morphologically the cells had a typical phenotype with flat and large cell bodies and long 
protruding processes. Immunocytochemistry and western blotting could confirm the 
expression of the previously reported pericyte markers NG2, PDGFR-β, and αSMA. 
However, in accordance with previous reports, even the cells isolated from the same muscle 
and tissue, were not a uniform population. 
A certain heterogeneity was also present in the functional studies investigating pericyte 
membrane channels by electrophysiology. In these experiments in a subset of the pericyte 
population the presence of the voltage sensitive potassium channel KV1.5 could be 
demonstrated. Upon pharmacological stimulation of these channels by FFA they were able to 
elicit a membrane hyperpolarization and conduct it to neighboring endothelial cells via gap 
junctions formed by connexin 43. The expression of the KV1.5 channel could also be 
demonstrated by immunohistochemistry in paraffin sections from hamster skeletal muscle. 
These findings are consistent with the hypothesis that pericytes could act as signal generators 
for hyperpolarization and vasodilatation in the vessel wall. The coupling with endothelial cells 
might relay an electric signal further along the vessel wall and lead to “EDHF mediated” 
dilations [48]. Interestingly in tissue sections KV1.5 positive pericytes were located 
predominantly at vascular branchings. 
We additionally studied whether gap junctions may also form a pathway for the exchange of 
miRNA between cells in a model co-culture system using HeLa. For the detection of the 
miRNA a detector system consisting of a luciferase reporter protein under control of a 
miR124 sensitive 3’ UTR was established. Our experiments could not conclusively confirm 
transfer of miRNA in this system. Similar results were obtained with human miR15b. 
Taken together these findings open up new possibilities for studying skeletal muscle pericyte 
physiology and to test novel concepts integrating the pericyte into the vascular signaling 
network under conditions of health and disease. 
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2. Zusammenfassung 
In diesem Promotionsprojekt wird eine neue Methode zur Isolation und Kultivierung von 
Perizyten aus der Skelettmuskulatur von Hamstern vorgestellt. Durch einen zwei stufigen 
Ansatz mittels selektiver Isolation von Zellen mit dem 3G5 Antigen und die Kultivierung in 
einem selektiven Wachstumsmedium konnte in den nachfolgenden 
Charakterisierungsschritten ein hoher Anteil an Perizyten nachgewiesen werden. 
Morphologisch hatten die Zellen einen Phänotyp mit typischem flachen und großen 
Zellkörper und langen Fortsätzen. In der Immunhistochemie und im Western Blot konnte die 
Expression der bekannten Perizytenmarker NG2, PDGFR-β, und αSMA bestätigt werden. In 
Übereinstimmung mit der Literatur waren sowohl Morphologie, als auch die 
Markerexpression nicht einheitlich, sogar bei Zellen aus demselben Muskel und Gewebe. 
Dies ist mit der Existenz von funktionell unterschiedlichen Populationen von Perizyten 
vereinbar. 
Eine Heterogenität der isolierten Perizyten zeigte sich auch in den funktionellen 
Untersuchungen der Perizytenmembran mittels Elektrophysiologie. Bei diesen Experimenten 
konnte in einem Teil der Perizytenpopulation der spannungsabhängige Kaliumkanal KV1.5 
nachgewiesen werden. Durch pharmakologische Stimulation dieses Kanals mit Flufenamsäure 
(FFA) konnte in den Zellen eine Hyperpolarisation der Zellmembran erzeugt werden, die über 
durch Connexin 43 gebildete gap junction Kanäle an benachbarte Endothelzellen 
weitergeleitet werden konnte. Das Vorhandensein von KV1.5 konnte auch 
immunhistochemisch an Paraffinschnitten aus Hamstermuskel nachgewiesen werden. Diese 
Ergebnisse sind gut vereinbar mit der Hypothese, dass Perizyten als Signalgeneratoren für 
eine Hyperpolarisation der Gefäßzellen dienen und so eine Vasodilatation induzieren. Durch 
Kopplung von Perizyten und Endothelzellen kann ein elektrisches Signal entlang der 
Gefäßwand stromaufwärts eine „EDHF ähnliche“ Vasodilatation auslösen. Interessanterweise 
befanden sich KV1.5 positive Perizyten in Gewebeschnitten bevorzugt an Aufzweigungen von 
Gefäßen. 
Zusätzlich untersuchten wir mit Hilfe eines HeLa Ko-Kultursystemes die Möglichkeit des 
direkten Austausches von miRNA über gap junctions. Zur miRNA Detektion etablierten wir 
einen Luciferasereporters, der unter der Kontrolle einer miR124 sensitiven 3‘ UTR stand. 
Nach zwei Tagen Ko-Kultur ließ sich jedoch  nicht schlüssig zeigen, dass ein solcher Transfer 
von miRNA stattfand. Dies gilt auch für zusätzliche Experimente mit der humanen miR15b. 
Zusammenfassend eröffnen diese Ergebnisse neue Möglichkeiten die physiologischen 
Eigenschaften von Perizyten aus Skelettmuskel zu untersuchen und neue Konzepte zu testen, 
wie Perizyten im vaskulären Signalnetzwerk unter physiologischen Bedingungen bzw. bei 
Gefäßerkrankungen eingebunden sind. 
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3. Abbreviations 
4-AP 4-Aminopyridine 
A Ampère 
Ach Acetylcholine 
AGE Advanced glycation end-products 
Ago Argonaute 
APS Ammonium persulfate 
ATCC American type culture collection 
ATP Adenosine tri-phosphate 
BCA Bicinchoninic acid 
BMDC Bone marrow-derived cell 
BP Bandpass 
BSA Bovine serum albumine 
C. elegans Caenorhabditis elegans 
Ca
++
 Calcium 
cAMP Cyclic adenosine monophosphate 
CCD Charge coupled device 
CD Cluster of differentiation 
CNS Central nervous system 
CoA Coenzyme A 
COX Cyclo-oxygenase 
CR Complement receptor 
Cx Connexin 
CXCR CXC-motive receptor 
DGCR8 DiGeorge syndrome critical region 8 
DiBAC4(3) Bis[1,3-dibutylbarbituric acid]trimethine oxonol 
DM Dichroic mirror 
D-MEM Dulbecco’s modified Eagles medium 
DMSO Di-methyl sulphoxide 
DNA Desoxi-ribonucleic acid 
DNAse Desoxy ribonuclease 
EC Endothelial cell 
EDHF Endothelium derived hyperpolarizing factor 
EDTA Ethylenediaminetetraacetic acid 
EET Epoxyeicosatrienoic acid 
EGTA Ethylene glycol tetraacetic acid 
F Farad 
FACS Fluorescence assisted cell scanning / sorting 
FCS Fetal calf serum 
FFA Flufenamic acid 
FITC Fluorescein iso-thio cyanate 
FSC Forward scatter 
g Gram / g-force 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GFP Green fluorescent protein 
GTP Guanosine tri-phosphate 
H2O2 Hydrogen-peroxide 
HEPES 4-(2-hydroxyethyl)-1-piperazine-ethane-sulfonic acid 
HRP Horse radish peroxidase 
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HUVEC Human umbilical vein endothelial cell 
I/V Current / voltage 
IFN-γ / -α Interferon-γ / -α 
IgG Immunoglobulin G 
IgM Immunoglobulin M 
IKCa Ca
++
 sensitive, intermediate-conductance potassium channel 
IL Interleukin 
IP3 Inositol tri-phosphate 
K
+
 Potassium 
LAR Luciferase assay reagent 
LMU Ludwig Maximilians Universität 
LNA N
ω
-nitro-L-arginine 
LP Longpass 
LPS Lipopolysaccharide 
m Meter 
M Molar 
MACS Magnetic cell separation 
Mg Magnesium 
MHC Major Histo-compatibility complex 
miRNA Micro RNA 
mRNA Messenger RNA 
Na
+
 Sodium 
NBCS Newborn calf serum 
NFκB Nuclear factor κ  
NO Nitric oxide 
NRK cells Normal rat kidney cells 
PAEC Porcine arterial endothelial cells 
PBS Phosphate buffered saline 
PC Pericyte 
PDGF Platelet-derived growth factor 
PDGFR-β Platelet-derived growth-factor receptor β 
PE Phycoerythrin 
PGI Prostaglandin I 
pH Potential Hydrogen 
PI Propidium Iodide 
PLB Passive lysis buffer 
PMN Polymorphonuclear neutrophils 
PMT Photomultiplier tube 
RIPA Radioimmunoprecipitation assay buffer 
RISC RNA-induced silencing complex 
RLU Relative luminescence units 
RNA Ribonucleic acid 
RNAi RNA interference 
RNAse Ribonuclease 
rpm Rotations per minute 
s Second 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
SEM Standard error of mean 
SFM Serum free medium 
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shRNA Small hairpin RNA 
siRNA Small interfering RNA 
SMC Smooth muscle cell 
SOD Superoxide dismutase 
SP Shortpass 
SSC Side scatter 
Taq Thermophilus aquaticus 
TBS Tris buffered saline 
TEA Tetraethylammonium 
TEMED N,N,N’,N’-tetramethylethylenediamine 
TGF-β Transforming growth factor beta 
TNFα Tumor necrosis factor α 
TRITC Tetramethyl Rhodamine Iso-Thiocyanate 
TRP Transient receptor potential 
UTR Untranslated region 
VEGF Vascular endothelial growth factor 
VIP Vasoactive intestinal peptide 
vWF Von Willebrand factor 
wt Wildtype 
αSMA Smooth muscle actin 
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